| AADI |
Aadi Bioscience Inc |
-55 M |
|
-49 |
|
1.2 |
0.50 |
-270 |
-0.02 |
42.2 |
35 |
| ABCL |
AbCellera Biologics Inc |
664 M |
|
-12 |
|
6.7 |
1.2 |
0.00 |
-1.8 |
41.4 |
43 |
| ABEO |
Abeona Therapeutics Inc |
160 M |
|
-260 |
|
36 |
13 |
0.00 |
-0.15 |
59.7 |
82 |
| ABIO |
ARCA biopharma Inc |
-12 M |
|
-13 |
|
0.76 |
0.68 |
0.00 |
-0.06 |
30.8 |
24 |
| ABOS |
Acumen Pharmaceuticals Inc |
16 M |
|
-20 |
|
0.00 |
0.83 |
0.00 |
-0.00 |
24.7 |
9 |
| ABSI |
Absci Corporation |
351 M |
|
-43 |
|
9.0 |
2.3 |
0.00 |
-0.26 |
44.6 |
47 |
| ABUS |
Arbutus Biopharma Corporation |
324 M |
|
-59 |
|
1.7 |
4.0 |
0.00 |
-0.02 |
42.4 |
39 |
| ABVC |
ABVC BioPharma Inc |
14 M |
|
-191 |
|
30 |
1.1 |
0.00 |
-0.58 |
52.1 |
65 |
| ABVX |
Abivax SA |
553 M |
|
-211 |
|
51 |
7.8 |
0.00 |
-0.73 |
62.0 |
89 |
| ACAD |
ACADIA Pharmaceuticals Inc |
2.7 B |
|
-14 |
|
13 |
7.1 |
-8.4 |
3.4 |
46.2 |
47 |
| ACET |
Adicet Bio Inc |
-51 M |
|
-61 |
|
12 |
0.52 |
0.00 |
-0.22 |
41.6 |
42 |
| ACHL |
Achilles Therapeutics plc |
-84 M |
|
-42 |
|
4.8 |
0.32 |
0.00 |
-0.14 |
35.9 |
32 |
| ACHV |
Achieve Life Sciences Inc |
93 M |
|
-1399 |
|
403 |
23 |
0.00 |
-0.52 |
68.2 |
110 |
| ACIU |
AC Immune SA |
216 M |
|
-32 |
|
2.2 |
2.0 |
0.00 |
-0.06 |
37.7 |
33 |
| ACLX |
Arcellx Inc |
3.3 B |
|
-20 |
|
20 |
7.9 |
-64 |
0.47 |
48.7 |
50 |
| ACRV |
Acrivon Therapeutics Inc |
-16 M |
|
-46 |
|
3.2 |
0.88 |
0.00 |
-0.11 |
37.7 |
35 |
| ACST |
Acasti Pharma Inc |
6.9 M |
|
-48 |
|
0.04 |
0.49 |
0.00 |
-0.00 |
26.2 |
12 |
| ACXP |
Acurx Pharmaceuticals Inc |
26 M |
|
-243 |
|
|
6.5 |
0.00 |
|
72.2 |
120 |
| ADAP |
Adaptimmune Therapeutics plc |
2.0 B |
|
-187 |
|
63 |
8.1 |
-188 |
-0.18 |
69.2 |
111 |
| ADCT |
ADC Therapeutics SA |
535 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| ADIL |
Adial Pharmaceuticals |
1.7 M |
|
-247 |
|
|
0.86 |
0.00 |
|
63.6 |
93 |
| ADMA |
ADMA Biologics Inc |
1.5 B |
|
-19 |
|
104 |
10.0 |
-10.0 |
16 |
54.4 |
68 |
| ADPT |
Adaptive Biotechnologies Corporation |
357 M |
|
-58 |
|
74 |
1.5 |
-132 |
-1.5 |
60.9 |
85 |
| ADTX |
Aditxt Inc |
6.1 M |
|
-698 |
|
|
|
0.00 |
|
76.7 |
135 |
| ADVM |
Adverum Biotechnologies Inc |
321 M |
|
-88 |
|
89 |
2.0 |
0.00 |
-0.83 |
55.4 |
73 |
| ADXN |
Addex Therapeutics Ltd |
970 M |
|
-190 |
|
8.2 |
245 |
0.00 |
-0.03 |
54.3 |
64 |
| AEON |
AEON Biopharma Inc |
519 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| AEZS |
Aeterna Zentaris Inc |
-28 M |
|
-61 |
|
0.83 |
0.39 |
0.00 |
-0.01 |
32.3 |
25 |
| AFMD |
Affimed N V |
-237 K |
|
-92 |
|
27 |
1.00 |
0.00 |
-0.18 |
47.3 |
54 |
| AGE |
AgeX Therapeutics Inc |
53 M |
|
|
|
26 |
|
0.00 |
|
70.6 |
107 |
| AGEN |
Agenus Inc |
265 M |
|
|
|
|
|
-157 |
|
86.9 |
178 |
| AGIO |
Agios Pharmaceuticals Inc |
986 M |
|
-36 |
|
8.9 |
2.1 |
0.00 |
-0.24 |
43.2 |
44 |
| AIM |
AIM ImmunoTech Inc |
-1.2 M |
|
-63 |
|
3.3 |
0.90 |
0.00 |
-0.04 |
38.0 |
35 |
| AKBA |
Akebia Therapeutics Inc |
444 M |
|
|
|
|
|
-26 |
|
84.2 |
166 |
| AKRO |
Akero Therapeutics Inc |
931 M |
|
-35 |
|
4.9 |
2.7 |
0.00 |
-0.18 |
42.6 |
43 |
| AKTX |
Akari Therapeutics Plc |
20 B |
|
-178 |
|
|
3.5 |
0.00 |
|
69.1 |
110 |
| ALDX |
Aldeyra Therapeutics Inc |
41 M |
|
-27 |
|
13 |
1.4 |
0.00 |
-0.52 |
42.4 |
43 |
| ALEC |
Alector Inc |
84 M |
|
-74 |
|
29 |
3.9 |
-134 |
-0.21 |
61.2 |
87 |
| ALGS |
Aligos Therapeutics Inc |
-54 M |
|
-89 |
|
12 |
0.76 |
0.00 |
-0.14 |
43.7 |
46 |
| ALLK |
Allakos Inc |
-19 M |
|
-77 |
|
24 |
0.65 |
0.00 |
-0.36 |
45.8 |
51 |
| ALLO |
Allogene Therapeutics Inc |
389 M |
|
-55 |
|
18 |
1.4 |
0.00 |
-0.40 |
45.9 |
51 |
| ALLR |
Allarity Therapeutics Inc |
4.9 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| ALNY |
Alnylam Pharmaceuticals Inc |
19 B |
|
|
|
|
|
-24 |
|
84.1 |
166 |
| ALPN |
Alpine Immune Sciences Inc |
1.9 B |
|
-12 |
|
|
6.7 |
-54 |
|
69.8 |
114 |
| ALRN |
Aileron Therapeutics Inc |
12 M |
|
-76 |
|
|
2.2 |
0.00 |
|
63.8 |
92 |
| ALT |
Altimmune Inc |
330 M |
|
-44 |
|
0.52 |
3.1 |
0.00 |
-0.01 |
37.5 |
30 |
| ALVR |
AlloVir Inc |
-73 M |
|
-102 |
|
18 |
0.57 |
0.00 |
-0.22 |
45.2 |
50 |
| ALXO |
ALX Oncology Holdings Inc |
414 M |
|
-70 |
|
9.1 |
3.0 |
0.00 |
-0.13 |
47.3 |
52 |
| ALZN |
Alzamend Neuro Inc |
7.3 M |
|
-496 |
|
|
|
0.00 |
|
76.5 |
134 |
| AMLX |
Amylyx Pharmaceuticals Inc |
-169 M |
4.2 |
12 |
|
0.98 |
0.45 |
12 |
0.36 |
6.8 |
1 |
| AMPE |
Ampio Pharmaceuticals Inc |
-4.7 M |
|
-91 |
|
6.7 |
0.24 |
0.00 |
-0.03 |
38.0 |
35 |
| ANAB |
AnaptysBio Inc |
560 M |
|
-93 |
|
372 |
7.0 |
0.00 |
-2.7 |
65.2 |
99 |
| ANEB |
Anebulo Pharmaceuticals Inc |
56 M |
|
-95 |
|
|
9.6 |
0.00 |
|
70.6 |
114 |
| ANIX |
Anixa Biosciences Inc |
90 M |
|
-43 |
|
0.69 |
4.6 |
0.00 |
-0.02 |
40.0 |
34 |
| ANL |
Adlai Nortye Ltd |
676 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| ANNX |
Annexon Inc |
190 M |
|
-67 |
|
20 |
2.1 |
0.00 |
-0.25 |
48.2 |
55 |
| ANRO |
Alto Neuroscience Inc |
156 M |
|
|
|
27 |
|
0.00 |
|
70.7 |
107 |
| ANVS |
Annovis Bio Inc |
85 M |
|
-227 |
|
|
12 |
0.00 |
|
73.3 |
124 |
| APGE |
Apogee Therapeutics Inc |
3.0 B |
|
-32 |
|
0.54 |
8.8 |
0.00 |
-0.03 |
41.3 |
35 |
| APLM |
Apollomics Inc |
3.0 M |
|
|
|
3.5 |
0.96 |
0.00 |
-0.04 |
45.4 |
48 |
| APLS |
Apellis Pharmaceuticals Inc |
6.6 B |
|
-290 |
|
57 |
34 |
-133 |
-0.19 |
70.6 |
116 |
| APLT |
Applied Therapeutics Inc |
614 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| APM |
Aptorum Group Limited |
41 M |
|
-108 |
|
3.9 |
2.3 |
0.00 |
-0.04 |
44.7 |
46 |
| APRE |
Aprea Therapeutics Inc |
1.1 M |
0.55 |
-51 |
|
|
1.2 |
0.00 |
|
49.3 |
45 |
| APTO |
Aptose Biosciences Inc |
-4.9 M |
|
-180 |
|
14 |
1.5 |
0.00 |
-0.03 |
46.2 |
51 |
| APVO |
Aptevo Therapeutics Inc |
-8.1 M |
|
-123 |
|
49 |
0.18 |
0.00 |
-0.52 |
48.2 |
56 |
| ARCT |
Arcturus Therapeutics Holdings Inc |
647 M |
|
-10.0 |
|
10.0 |
3.3 |
-17 |
-1.7 |
52.4 |
69 |
| ARDX |
Ardelyx Inc |
1.7 B |
|
-49 |
|
33 |
11 |
-53 |
-0.62 |
62.7 |
94 |
| ARGX |
argenx SE |
18 B |
|
-8.5 |
|
0.49 |
5.2 |
-23 |
-0.05 |
44.2 |
46 |
| ARMP |
Armata Pharmaceuticals Inc |
226 M |
|
-358 |
|
|
|
0.00 |
|
76.2 |
133 |
| ARQT |
Arcutis Biotherapeutics Inc |
889 M |
|
-175 |
|
232 |
10.0 |
0.00 |
-0.83 |
66.0 |
103 |
| ARTL |
Artelo Biosciences Inc |
-8.0 M |
|
-52 |
|
0.22 |
0.33 |
0.00 |
-0.00 |
26.2 |
12 |
| ARVN |
Arvinas Inc |
1.6 B |
|
-59 |
|
0.48 |
4.4 |
0.00 |
-0.01 |
40.6 |
34 |
| ARWR |
Arrowhead Pharmaceuticals Inc |
3.6 B |
|
-106 |
|
225 |
18 |
-163 |
-2.0 |
75.4 |
135 |
| ASLN |
ASLAN Pharmaceuticals Limited |
303 M |
|
-426 |
|
|
|
0.00 |
|
76.3 |
134 |
| ASMB |
Assembly Biosciences Inc |
19 M |
|
-100 |
|
2.2 |
1.2 |
0.00 |
-0.01 |
39.1 |
35 |
| ASND |
Ascendis Pharma A/S |
8.5 B |
|
-818 |
|
|
|
-180 |
|
85.7 |
174 |
| ATAI |
ATAI Life Sciences N V |
89 M |
|
-25 |
|
7.1 |
1.00 |
0.00 |
-0.20 |
38.4 |
36 |
| ATHA |
Athira Pharma Inc |
-60 M |
|
-64 |
|
1.2 |
0.66 |
0.00 |
-0.02 |
34.9 |
29 |
| ATHE |
Alterity Therapeutics Limited |
4.7 B |
|
-53 |
|
1.4 |
278 |
0.00 |
-0.02 |
45.8 |
43 |
| ATNM |
Actinium Pharmaceuticals Inc |
144 M |
|
-87 |
|
5.1 |
5.2 |
0.00 |
-0.05 |
48.4 |
52 |
| ATOS |
Atossa Therapeutics Inc |
101 M |
|
-26 |
|
|
2.0 |
0.00 |
|
58.2 |
73 |
| ATRA |
Atara Biotherapeutics Inc |
19 M |
|
-425 |
|
|
|
0.00 |
|
76.3 |
134 |
| ATXS |
Astria Therapeutics Inc |
765 M |
|
-31 |
|
0.14 |
4.6 |
0.00 |
-0.00 |
33.1 |
19 |
| AUPH |
Aurinia Pharmaceuticals Inc |
496 M |
|
-19 |
|
25 |
2.0 |
-44 |
-2.9 |
54.2 |
71 |
| AURA |
Aura Biosciences Inc |
157 M |
|
-53 |
|
13 |
1.9 |
0.00 |
-0.31 |
45.7 |
50 |
| AUTL |
Autolus Therapeutics plc |
840 M |
|
-101 |
|
|
9.7 |
0.00 |
|
70.9 |
115 |
| AVBP |
ArriVent BioPharma Inc |
187 M |
|
|
|
0.03 |
|
0.00 |
|
63.1 |
73 |
| AVIR |
Atea Pharmaceuticals Inc |
-244 M |
|
-22 |
|
0.43 |
0.59 |
0.00 |
-0.03 |
29.8 |
22 |
| AVRO |
AVROBIO Inc |
-41 M |
4.7 |
14 |
|
0.93 |
0.59 |
0.00 |
-0.01 |
16.4 |
7 |
| AVTE |
Aerovate Therapeutics Inc |
577 M |
|
-52 |
|
0.64 |
5.7 |
0.00 |
-0.01 |
41.3 |
35 |
| AVTX |
Avalo Therapeutics Inc |
-4.7 M |
|
-524 |
|
13 |
0.24 |
0.00 |
-0.06 |
44.0 |
48 |
| AVXL |
Anavex Life Sciences Corp |
254 M |
|
-31 |
|
|
2.9 |
0.00 |
|
60.7 |
81 |
| AXSM |
Axsome Therapeutics Inc |
3.4 B |
|
-159 |
|
97 |
19 |
-88 |
-1.3 |
73.8 |
129 |
| BBIO |
BridgeBio Pharma Inc |
6.3 B |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| BCAB |
BioAtla Inc |
-21 M |
|
-104 |
|
3.0 |
1.2 |
0.00 |
-0.03 |
40.9 |
39 |
| BCDA |
BioCardia Inc |
7.8 M |
|
-728 |
|
|
|
0.00 |
|
76.8 |
135 |
| BCLI |
Brainstorm Cell Therapeutics Inc |
19 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| BCRX |
BioCryst Pharmaceuticals Inc |
1.6 B |
|
|
|
|
|
-68 |
|
85.5 |
172 |
| BCTX |
BriaCell Therapeutics Corp |
37 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| BCYC |
Bicycle Therapeutics plc |
564 M |
|
-56 |
|
12 |
2.8 |
0.00 |
-0.74 |
49.4 |
58 |
| BDRX |
Biodexa Pharmaceuticals plc |
282 M |
|
-127 |
|
10.0 |
0.14 |
0.00 |
-0.07 |
41.0 |
41 |
| BDTX |
Black Diamond Therapeutics Inc |
133 M |
|
-70 |
|
21 |
2.0 |
0.00 |
-0.38 |
48.9 |
57 |
| BEAM |
Beam Therapeutics Inc |
1.7 B |
|
-15 |
|
17 |
2.8 |
-35 |
-1.2 |
53.4 |
70 |
| BGNE |
BeiGene Ltd |
226 B |
|
-22 |
|
26 |
5.0 |
-35 |
-0.80 |
57.0 |
79 |
| BHVN |
Biohaven Ltd |
4.3 B |
|
-84 |
|
7.2 |
10.0 |
0.00 |
-0.09 |
51.6 |
59 |
| BIOR |
Biora Therapeutics Inc |
99 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| BIVI |
BioVie Inc |
15 M |
|
-257 |
|
136 |
3.3 |
0.00 |
-0.25 |
59.8 |
86 |
| BLRX |
BioLineRx Ltd |
1.1 B |
|
-152 |
|
101 |
84 |
0.00 |
-0.40 |
64.2 |
96 |
| BLTE |
Belite Bio |
1.2 B |
|
-47 |
|
0.98 |
14 |
0.00 |
-0.03 |
44.2 |
40 |
| BLUE |
bluebird bio Inc |
282 M |
|
-47 |
|
136 |
0.67 |
0.00 |
-1.1 |
49.9 |
56 |
| BMEA |
Biomea Fusion Inc |
360 M |
|
-65 |
|
6.1 |
2.7 |
0.00 |
-0.13 |
45.5 |
48 |
| BMRN |
BioMarin Pharmaceutical Inc |
16 B |
98 |
3.5 |
|
22 |
3.2 |
6.9 |
7.1 |
26.0 |
16 |
| BNOX |
Bionomics Limited |
2.0 B |
|
-80 |
|
5.4 |
0.38 |
0.00 |
-0.06 |
38.6 |
37 |
| BNTC |
Benitec Biopharma Inc |
-6.8 M |
|
-178 |
|
2.7 |
0.85 |
0.00 |
-0.02 |
40.7 |
39 |
| BNTX |
BioNTech SE |
6.8 B |
7.7 |
14 |
|
1.00 |
1.1 |
41 |
0.04 |
7.8 |
1 |
| BOLT |
Bolt Biotherapeutics Inc |
-55 M |
|
-45 |
|
16 |
0.34 |
0.00 |
-0.28 |
40.2 |
39 |
| BPMC |
Blueprint Medicines Corporation |
5.5 B |
|
-157 |
|
592 |
41 |
-203 |
-1.8 |
77.7 |
143 |
| BPTH |
Bio Path Holdings Inc |
2.2 M |
|
-220 |
|
25 |
6.4 |
0.00 |
-0.01 |
53.6 |
66 |
| BPTS |
Biophytis SA |
169 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| BRNS |
Barinthus Biotherapeutics plc |
-54 M |
|
-35 |
|
6.5 |
|
0.00 |
|
57.5 |
72 |
| BRTX |
BioRestorative Therapies Inc |
-5.4 M |
|
-106 |
|
1.5 |
0.51 |
0.00 |
-0.03 |
37.6 |
34 |
| BTAI |
BioXcel Therapeutics Inc |
90 M |
|
-990 |
|
|
|
0.00 |
|
76.9 |
136 |
| BYSI |
BeyondSpring Inc |
110 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| CABA |
Cabaletta Bio Inc |
611 M |
|
-50 |
|
2.7 |
4.7 |
0.00 |
-0.09 |
44.7 |
45 |
| CADL |
Candel Therapeutics Inc |
23 M |
|
-84 |
|
98 |
1.9 |
0.00 |
-0.68 |
54.7 |
71 |
| CALC |
CalciMedica Inc |
4.7 M |
0.04 |
-2359 |
|
|
1.6 |
0.00 |
|
57.2 |
63 |
| CALT |
Calliditas Therapeutics AB |
1.1 B |
|
-84 |
|
288 |
|
-38 |
|
77.0 |
141 |
| CANF |
Can Fite Biopharma Ltd |
2.7 B |
|
-142 |
|
0.97 |
545 |
0.00 |
-0.01 |
48.9 |
46 |
| CAPR |
Capricor Therapeutics Inc |
176 M |
|
-129 |
|
9.9 |
9.4 |
-88 |
-0.09 |
61.5 |
86 |
| CARA |
Cara Therapeutics Inc |
-8.9 M |
|
-109 |
|
75 |
0.85 |
0.00 |
-0.47 |
51.8 |
64 |
| CARM |
Carisma Therapeutics Inc |
2.2 M |
|
-590 |
|
5.9 |
2.0 |
0.00 |
-0.03 |
46.9 |
51 |
| CASI |
CASI Pharmaceuticals Inc |
27 M |
|
-59 |
|
|
1.4 |
-95 |
|
68.2 |
103 |
| CBAY |
CymaBay Therapeutics Inc |
3.4 B |
|
-64 |
|
39 |
12 |
0.00 |
-1.6 |
59.3 |
80 |
| CBUS |
Cibus Inc |
455 M |
|
-21 |
|
4.5 |
0.71 |
0.00 |
-0.80 |
38.5 |
38 |
| CDIO |
Cardio Diagnostics Holdings Inc |
24 M |
|
-157 |
|
81 |
7.3 |
0.00 |
-0.26 |
61.1 |
88 |
| CDMO |
Avid Bioservices Inc |
609 M |
|
-6.3 |
|
107 |
2.4 |
-8.1 |
115 |
47.9 |
46 |
| CDT |
Conduit Pharmaceuticals Inc |
224 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| CDTX |
Cidara Therapeutics Inc |
20 M |
|
-358 |
|
54 |
8.0 |
-54 |
-0.14 |
67.1 |
105 |
| CDXC |
ChromaDex Corporation |
181 M |
|
-17 |
|
11 |
7.2 |
-5.9 |
0.46 |
44.6 |
42 |
| CDXS |
Codexis Inc |
181 M |
|
-65 |
|
18 |
2.6 |
-108 |
-0.30 |
57.3 |
77 |
| CELC |
Celcuity Inc |
339 M |
|
-82 |
|
39 |
4.3 |
0.00 |
-0.83 |
56.6 |
75 |
| CELU |
Celularity Inc |
162 M |
|
-186 |
|
201 |
3.3 |
0.00 |
-0.96 |
62.4 |
92 |
| CELZ |
Creative Medical Technology Holdings I |
-4.9 M |
|
-57 |
|
0.12 |
0.59 |
0.00 |
-0.00 |
27.8 |
14 |
| CERE |
Cerevel Therapeutics Holdings Inc |
7.2 B |
|
-72 |
|
71 |
11 |
0.00 |
-1.4 |
61.4 |
87 |
| CERO |
CERo Therapeutics Holdings Inc |
16 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| CGEM |
Cullinan Oncology Inc |
204 M |
|
-31 |
|
0.79 |
1.5 |
0.00 |
-0.03 |
33.9 |
27 |
| CGEN |
Compugen Ltd |
182 M |
|
-26 |
|
2.1 |
3.5 |
-56 |
-0.04 |
46.5 |
50 |
| CGTX |
Cognition Therapeutics Inc |
23 M |
|
-66 |
|
2.5 |
1.9 |
0.00 |
-0.04 |
40.4 |
38 |
| CHRO |
Chromocell Therapeutics Corporation |
28 M |
|
-26 |
|
|
|
0.00 |
|
67.4 |
102 |
| CHRS |
Coherus BioSciences Inc |
639 M |
|
|
|
|
|
-92 |
|
86.1 |
174 |
| CING |
Cingulate Inc |
2.6 M |
|
-512 |
|
|
|
0.00 |
|
76.5 |
134 |
| CKPT |
Checkpoint Therapeutics Inc |
42 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| CLDI |
Calidi Biotherapeutics Inc |
27 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| CLDX |
Celldex Therapeutics Inc |
1.8 B |
|
-37 |
|
0.59 |
5.3 |
0.00 |
-0.02 |
39.9 |
33 |
| CLGN |
CollPlant Biotechnologies Ltd |
34 M |
|
-19 |
|
9.6 |
1.8 |
-62 |
-0.82 |
50.0 |
61 |
| CLLS |
Cellectis S A |
150 M |
|
-71 |
|
109 |
1.8 |
0.00 |
-1.3 |
55.1 |
71 |
| CLNN |
Clene Inc |
49 M |
|
-595 |
|
240 |
3.9 |
0.00 |
-1.1 |
64.9 |
100 |
| CLRB |
Cellectar Biosciences Inc |
47 M |
|
-435 |
|
12 |
|
0.00 |
|
66.9 |
95 |
| CLSD |
Clearside Biomedical Inc |
136 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| CMMB |
Chemomab Therapeutics Ltd |
197 M |
|
-91 |
|
2.3 |
0.64 |
0.00 |
-0.02 |
37.5 |
33 |
| CMND |
Clearmind Medicine Inc |
-1.4 M |
|
|
|
|
0.80 |
0.00 |
|
65.8 |
101 |
| CMPX |
Compass Therapeutics Inc |
111 M |
|
-29 |
|
1.3 |
1.7 |
0.00 |
-0.05 |
35.5 |
30 |
| CMRX |
Chimerix Inc |
-95 M |
|
-36 |
|
0.94 |
0.44 |
0.00 |
-0.03 |
31.1 |
24 |
| CNSP |
CNS Pharmaceuticals Inc |
1.3 M |
|
-559 |
|
|
|
0.00 |
|
76.6 |
135 |
| CNTA |
Centessa Pharmaceuticals plc |
893 M |
|
-49 |
|
32 |
4.2 |
0.00 |
-0.46 |
52.2 |
64 |
| CNTB |
Connect Biopharma Holdings Limited |
-881 M |
|
-51 |
|
0.46 |
0.07 |
0.00 |
-0.01 |
29.7 |
21 |
| CNTX |
Context Therapeutics Inc |
-4.1 M |
|
-73 |
|
|
0.96 |
0.00 |
|
60.3 |
81 |
| COCP |
Cocrystal Pharma Inc |
-15 M |
|
-48 |
|
0.38 |
0.47 |
0.00 |
-0.01 |
30.7 |
22 |
| COEP |
Coeptis Therapeutics Holdings Inc |
10 M |
|
-343 |
|
19 |
2.0 |
0.00 |
-0.16 |
51.5 |
63 |
| COGT |
Cogent Biosciences Inc |
513 M |
|
-74 |
|
7.3 |
2.9 |
0.00 |
-0.12 |
46.9 |
51 |
| CORT |
Corcept Therapeutics Incorporated |
2.1 B |
25 |
21 |
|
0.03 |
4.9 |
22 |
0.00 |
13.5 |
1 |
| COYA |
Coya Therapeutics Inc |
90 M |
|
-522 |
|
|
9.9 |
0.00 |
|
73.9 |
126 |
| CPRX |
Catalyst Pharmaceuticals Inc |
1.8 B |
26 |
20 |
|
0.92 |
4.5 |
17 |
0.02 |
14.9 |
3 |
| CRBP |
Corbus Pharmaceuticals Holdings Inc |
449 M |
|
-341 |
|
|
|
0.00 |
|
76.1 |
133 |
| CRBU |
Caribou Biosciences Inc |
185 M |
|
-30 |
|
7.4 |
1.3 |
-296 |
-0.29 |
49.9 |
58 |
| CRDF |
Cardiff Oncology Inc |
145 M |
|
-47 |
|
3.1 |
3.1 |
0.00 |
-0.07 |
42.2 |
41 |
| CRGX |
CARGO Therapeutics Inc |
1.2 B |
|
|
|
7.1 |
|
0.00 |
|
67.5 |
93 |
| CRIS |
Curis Inc |
6.7 M |
|
-143 |
|
14 |
3.1 |
0.00 |
-0.07 |
50.3 |
59 |
| CRMD |
CorMedix Inc |
135 M |
|
-74 |
|
0.95 |
3.0 |
0.00 |
-0.02 |
41.3 |
37 |
| CRNX |
Crinetics Pharmaceuticals Inc |
2.6 B |
|
-50 |
|
9.6 |
5.7 |
0.00 |
-0.31 |
50.1 |
57 |
| CRSP |
CRISPR Therapeutics AG |
4.3 B |
|
-8.2 |
|
12 |
3.1 |
-41 |
-0.92 |
52.4 |
68 |
| CRVO |
CervoMed Inc |
128 M |
|
|
|
|
14 |
-28 |
|
82.1 |
158 |
| CRVS |
Corvus Pharmaceuticals Inc |
70 M |
|
-57 |
|
3.6 |
2.5 |
0.00 |
-0.06 |
42.3 |
41 |
| CSBR |
Champions Oncology Inc |
73 M |
|
-388 |
|
|
|
-19 |
|
81.9 |
158 |
| CTCX |
Carmell Corporation |
58 M |
|
-261 |
|
46 |
2.7 |
0.00 |
-1.3 |
58.9 |
82 |
| CTMX |
CytomX Therapeutics Inc |
-13 M |
|
|
|
|
|
-0.56 |
|
82.5 |
159 |
| CTXR |
Citius Pharmaceuticals Inc |
99 M |
|
-40 |
|
0.50 |
1.4 |
0.00 |
-0.01 |
33.2 |
25 |
| CUE |
Cue Biopharma Inc |
47 M |
|
-111 |
|
38 |
2.0 |
0.00 |
-0.41 |
52.8 |
67 |
| CVAC |
CureVac N V |
236 M |
|
-49 |
|
7.0 |
1.1 |
0.00 |
-0.15 |
40.6 |
40 |
| CVKD |
Cadrenal Therapeutics Inc |
744 K |
|
-780 |
|
0.28 |
0.96 |
0.00 |
-0.01 |
39.7 |
35 |
| CVM |
Cel Sci Corporation |
112 M |
|
-158 |
|
103 |
8.0 |
0.00 |
-0.57 |
63.1 |
94 |
| CYBN |
Cybin Inc |
143 M |
|
-79 |
|
0.30 |
1.5 |
0.00 |
-0.01 |
36.7 |
30 |
| CYCC |
Cyclacel Pharmaceuticals Inc |
-1.3 M |
|
-272 |
|
6.1 |
3.3 |
0.00 |
-0.00 |
43.7 |
41 |
| CYCN |
Cyclerion Therapeutics Inc |
300 K |
|
-115 |
|
|
0.68 |
0.00 |
|
61.2 |
85 |
| CYTK |
Cytokinetics |
7.1 B |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| CYTO |
Altamira Therapeutics Ltd |
4.1 M |
|
-964 |
|
|
|
0.00 |
|
76.9 |
136 |
| DARE |
Dare Bioscience Inc |
37 M |
|
-341 |
|
|
|
0.00 |
|
76.1 |
133 |
| DAWN |
Day One Biopharmaceuticals Inc |
840 M |
|
-55 |
|
0.12 |
3.5 |
0.00 |
-0.00 |
34.7 |
21 |
| DBVT |
DBV Technologies S A |
-59 M |
|
-43 |
|
4.0 |
0.55 |
0.00 |
-0.07 |
35.6 |
31 |
| DMAC |
DiaMedica Therapeutics Inc |
55 M |
|
-46 |
|
0.78 |
2.1 |
0.00 |
-0.02 |
36.7 |
30 |
| DNA |
Ginkgo Bioworks Holdings Inc |
1.5 B |
|
-63 |
|
22 |
2.0 |
0.00 |
-0.82 |
49.7 |
59 |
| DNLI |
Denali Therapeutics Inc |
1.9 B |
|
-14 |
|
5.1 |
2.8 |
-43 |
-0.15 |
47.4 |
54 |
| DNTH |
Dianthus Therapeutics Inc |
203 M |
|
|
|
0.38 |
2.2 |
0.00 |
-0.02 |
45.1 |
42 |
| DOMH |
Dominari Holdings Inc |
-4.9 M |
|
-33 |
|
6.1 |
0.21 |
0.00 |
-0.18 |
35.5 |
31 |
| DRMA |
Dermata Therapeutics Inc |
-5.4 M |
|
-105 |
|
|
0.19 |
0.00 |
|
58.8 |
77 |
| DRTS |
Alpha Tau Medical Ltd |
137 M |
|
-30 |
|
15 |
2.4 |
0.00 |
-0.74 |
46.2 |
51 |
| DRUG |
Bright Minds Biosciences Inc |
-1.3 M |
|
-79 |
|
0.90 |
0.90 |
0.00 |
-0.01 |
35.9 |
30 |
| DSGN |
Design Therapeutics Inc |
-133 M |
|
-22 |
|
0.84 |
0.53 |
0.00 |
-0.04 |
30.4 |
23 |
| DTIL |
Precision BioSciences Inc |
-51 M |
|
-153 |
|
82 |
1.6 |
-140 |
-0.24 |
62.5 |
87 |
| DYAI |
Dyadic International Inc |
38 M |
|
-67 |
|
1.9 |
6.0 |
-232 |
-0.02 |
54.0 |
64 |
| DYN |
Dyne Therapeutics Inc |
2.2 B |
|
-137 |
|
30 |
18 |
0.00 |
-0.15 |
58.4 |
78 |
| EDIT |
Editas Medicine Inc |
331 M |
|
-43 |
|
10.0 |
1.8 |
-196 |
-0.28 |
52.6 |
64 |
| EDSA |
Edesa Biotech Inc |
8.8 M |
|
-95 |
|
1.3 |
2.2 |
0.00 |
-0.01 |
40.9 |
37 |
| EFTR |
eFFECTOR Therapeutics Inc |
34 M |
|
-946 |
|
|
|
0.00 |
|
76.9 |
136 |
| EIGR |
Eiger BioPharmaceuticals Inc |
3.6 M |
|
-225 |
|
|
|
0.00 |
|
75.7 |
131 |
| ELAB |
Elevai Labs Inc |
13 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| ELDN |
Eledon Pharmaceuticals Inc |
-20 M |
|
-76 |
|
0.52 |
0.42 |
0.00 |
-0.01 |
33.3 |
26 |
| ELEV |
Elevation Oncology Inc |
161 M |
|
-88 |
|
54 |
3.4 |
0.00 |
-0.54 |
55.9 |
74 |
| ELTX |
Elicio Therapeutics Inc |
45 M |
|
|
|
46 |
4.0 |
0.00 |
-0.19 |
59.8 |
84 |
| ELVN |
Enliven Therapeutics Inc |
472 M |
|
-44 |
|
0.14 |
2.9 |
0.00 |
-0.01 |
36.5 |
28 |
| ELYM |
Eliem Therapeutics |
-30 M |
|
-32 |
|
0.42 |
0.70 |
0.00 |
-0.02 |
30.7 |
23 |
| ENGN |
enGene Holdings Inc |
723 M |
|
|
|
39 |
|
0.00 |
|
71.6 |
111 |
| ENLV |
Enlivex Therapeutics Ltd |
50 M |
|
-53 |
|
11 |
2.0 |
0.00 |
-0.20 |
44.9 |
48 |
| ENSC |
Ensysce Biosciences Inc |
5.5 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| ENTA |
Enanta Pharmaceuticals Inc |
-13 M |
|
-56 |
|
14 |
1.5 |
-187 |
-0.29 |
54.1 |
67 |
| ENTX |
Entera Bio Ltd |
39 M |
|
-80 |
|
3.8 |
4.8 |
0.00 |
-0.05 |
47.0 |
49 |
| ENVB |
Enveric Biosciences Inc |
-1.5 M |
|
-173 |
|
|
1.1 |
0.00 |
|
63.9 |
94 |
| EPIX |
ESSA Pharma Inc |
270 M |
|
-17 |
|
0.27 |
2.9 |
0.00 |
-0.02 |
34.7 |
26 |
| EQ |
Equillium Inc |
49 M |
|
-31 |
|
3.8 |
3.9 |
-19 |
0.08 |
41.7 |
34 |
| ERAS |
Erasca Inc |
69 M |
|
-65 |
|
16 |
0.91 |
0.00 |
-0.55 |
45.7 |
51 |
| ERNA |
Eterna Therapeutics Inc |
47 M |
|
-302 |
|
1873 |
5.6 |
0.00 |
-2.1 |
67.5 |
107 |
| ESLA |
Estrella Immunopharma Inc |
31 M |
|
-220 |
|
0.07 |
4.3 |
0.00 |
-0.00 |
40.5 |
29 |
| EVAX |
Evaxion Biotech A/S |
132 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| EVGN |
Evogene Ltd |
27 M |
|
-81 |
|
4.0 |
3.4 |
0.00 |
-0.05 |
45.7 |
47 |
| EWTX |
Edgewise Therapeutics Inc |
1.2 B |
|
-30 |
|
1.7 |
3.6 |
0.00 |
-0.06 |
40.1 |
36 |
| EXAI |
Exscientia Plc |
430 M |
|
-31 |
|
4.7 |
2.0 |
0.00 |
-0.11 |
39.6 |
37 |
| EXEL |
Exelixis Inc |
6.3 B |
36 |
8.7 |
|
9.5 |
3.1 |
11 |
0.65 |
19.8 |
10 |
| EYEN |
Eyenovia Inc |
57 M |
|
-207 |
|
178 |
5.9 |
0.00 |
-0.67 |
64.1 |
97 |
| EYPT |
EyePoint Pharmaceuticals Inc |
776 M |
|
-39 |
|
2.1 |
4.1 |
-153 |
2.9 |
46.4 |
44 |
| FATE |
Fate Therapeutics Inc |
483 M |
|
-37 |
|
28 |
1.9 |
-253 |
-0.78 |
56.7 |
75 |
| FBIO |
Fortress Biotech Inc |
-11 M |
|
-414 |
|
|
1.00 |
-126 |
|
73.2 |
120 |
| FBLG |
FibroBiologics Inc |
347 M |
|
|
|
150 |
|
0.00 |
|
75.2 |
127 |
| FBRX |
Forte Biosciences Inc |
-6.6 M |
|
-84 |
|
|
0.86 |
0.00 |
|
60.6 |
83 |
| FENC |
Fennec Pharmaceuticals Inc |
307 M |
|
|
|
|
|
-154 |
|
86.9 |
178 |
| FGEN |
FibroGen |
209 M |
|
|
|
|
|
-192 |
|
87.2 |
179 |
| FHTX |
Foghorn Therapeutics Inc |
69 M |
|
|
|
|
|
-288 |
|
87.7 |
181 |
| FIXX |
Homology Medicines Inc |
-29 M |
|
-90 |
|
1.8 |
0.72 |
0.00 |
-0.01 |
36.9 |
32 |
| FNCH |
Finch Therapeutics Group Inc |
6.5 M |
|
-134 |
|
119 |
0.17 |
0.00 |
-0.73 |
51.5 |
63 |
| FOLD |
Amicus Therapeutics Inc |
3.7 B |
|
-107 |
|
277 |
21 |
-37 |
-6.4 |
74.1 |
130 |
| FTRE |
Fortrea Holdings Inc |
5.1 B |
|
-0.13 |
|
96 |
2.0 |
-0.11 |
10.0 |
45.0 |
39 |
| FULC |
Fulcrum Therapeutics Inc |
400 M |
|
-44 |
|
4.6 |
2.7 |
0.00 |
-0.12 |
42.8 |
43 |
| FUSN |
Fusion Pharmaceuticals Inc |
1.4 B |
|
-49 |
|
27 |
7.8 |
0.00 |
-0.63 |
54.4 |
68 |
| FWBI |
First Wave BioPharma Inc |
213 K |
0.00 |
-3139 |
|
7.1 |
1.00 |
0.00 |
-0.02 |
35.2 |
20 |
| GALT |
Galectin Therapeutics Inc |
174 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| GANX |
Gain Therapeutics Inc |
44 M |
|
-148 |
|
14 |
7.4 |
0.00 |
-0.06 |
53.8 |
65 |
| GBIO |
Generation Bio Co |
31 M |
|
-52 |
|
48 |
0.97 |
0.00 |
-1.9 |
49.7 |
58 |
| GDTC |
CytoMed Therapeutics Limited |
19 M |
|
-58 |
|
3.6 |
2.2 |
0.00 |
-0.16 |
43.4 |
44 |
| GERN |
Geron Corporation |
1.5 B |
|
-112 |
|
34 |
7.2 |
0.00 |
-0.51 |
58.7 |
80 |
| GHRS |
GH Research PLC |
406 M |
|
-15 |
|
0.45 |
2.6 |
0.00 |
-0.03 |
34.7 |
27 |
| GLMD |
Galmed Pharmaceuticals Ltd |
-12 M |
|
-48 |
|
|
0.08 |
0.00 |
|
54.5 |
62 |
| GLPG |
Galapagos NV |
-1.5 B |
|
-0.15 |
|
0.34 |
0.79 |
88 |
-0.02 |
21.2 |
11 |
| GLSI |
Greenwich LifeSciences Inc |
209 M |
|
-73 |
|
|
24 |
0.00 |
|
70.4 |
113 |
| GLTO |
Galecto Inc |
-12 M |
|
-81 |
|
0.77 |
0.64 |
0.00 |
-0.01 |
34.8 |
28 |
| GLUE |
Monte Rosa Therapeutics Inc |
161 M |
|
-60 |
|
25 |
1.9 |
0.00 |
-1.1 |
50.1 |
60 |
| GLYC |
GlycoMimetics Inc |
140 M |
|
-80 |
|
2.2 |
4.1 |
0.00 |
-0.03 |
44.9 |
44 |
| GMAB |
Genmab A/S |
-25 B |
30 |
14 |
|
2.4 |
0.06 |
26 |
0.10 |
6.6 |
0 |
| GMDA |
Gamida Cell Ltd |
76 M |
|
-1103 |
|
22308 |
129 |
0.00 |
-1.1 |
70.5 |
117 |
| GNFT |
GENFIT S A |
134 M |
|
-37 |
|
101 |
2.3 |
-116 |
-1.5 |
61.5 |
87 |
| GNLX |
Genelux Corporation |
130 M |
|
|
|
7.9 |
6.5 |
0.00 |
-0.13 |
56.9 |
71 |
| GNPX |
Genprex Inc |
-6.7 M |
|
-158 |
|
|
0.41 |
0.00 |
|
61.0 |
85 |
| GNTA |
Genenta Science S p A |
53 M |
|
-42 |
|
0.13 |
3.0 |
0.00 |
-0.00 |
32.3 |
18 |
| GOSS |
Gossamer Bio Inc |
230 M |
|
-480 |
|
338 |
5.0 |
0.00 |
-1.3 |
66.3 |
104 |
| GOVX |
GeoVax Labs Inc |
-2.1 M |
|
-160 |
|
|
0.69 |
0.00 |
|
62.3 |
89 |
| GPCR |
Structure Therapeutics Inc |
4.6 B |
|
-33 |
|
1.2 |
3.7 |
0.00 |
-0.07 |
40.4 |
37 |
| GRI |
GRI Bio Inc |
-3.1 M |
|
|
|
1.3 |
0.14 |
0.00 |
-0.01 |
39.1 |
36 |
| GRPH |
Graphite Bio Inc |
-5.1 M |
|
-51 |
|
0.20 |
0.97 |
0.00 |
-0.00 |
28.9 |
15 |
| GRTS |
Gritstone bio Inc |
291 M |
|
-124 |
|
202 |
5.1 |
0.00 |
-0.86 |
63.1 |
94 |
| GTBP |
GT Biopharma Inc |
-9.8 M |
|
-78 |
|
0.92 |
0.62 |
0.00 |
-0.01 |
34.7 |
28 |
| GUTS |
Fractyl Health Inc |
325 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| HALO |
Halozyme Therapeutics Inc |
6.4 B |
19 |
222 |
|
1827 |
61 |
33 |
3.9 |
31.4 |
28 |
| HCWB |
HCW Biologics Inc |
57 M |
|
-59 |
|
27 |
2.6 |
0.00 |
-0.29 |
49.8 |
59 |
| HEPA |
Hepion Pharmaceuticals Inc |
-8.1 M |
|
-118 |
|
1.5 |
0.57 |
0.00 |
-0.01 |
37.0 |
32 |
| HLVX |
HilleVax Inc |
537 M |
|
-36 |
|
17 |
2.7 |
0.00 |
-0.61 |
47.4 |
53 |
| HOOK |
HOOKIPA Pharma Inc |
-42 M |
|
-66 |
|
4.1 |
0.65 |
0.00 |
-0.12 |
39.2 |
38 |
| HOTH |
Hoth Therapeutics Inc |
-6.0 M |
|
-100 |
|
|
0.56 |
0.00 |
|
60.1 |
81 |
| HOWL |
Werewolf Therapeutics Inc |
171 M |
|
-31 |
|
46 |
2.1 |
-187 |
-1.6 |
58.8 |
81 |
| HRMY |
Harmony Biosciences Holdings Inc |
1.7 B |
15 |
29 |
|
41 |
3.9 |
22 |
0.89 |
21.4 |
13 |
| HRTX |
Heron Therapeutics Inc |
543 M |
|
|
|
|
|
-87 |
|
85.9 |
174 |
| HUMA |
Humacyte Inc |
281 M |
|
-114 |
|
52 |
9.7 |
0.00 |
-0.27 |
59.5 |
82 |
| IBIO |
iBio Inc |
18 M |
|
-148 |
|
187 |
0.37 |
0.00 |
-0.91 |
53.9 |
68 |
| IBRX |
ImmunityBio Inc |
4.1 B |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| ICCC |
ImmuCell Corporation |
53 M |
|
-20 |
|
64 |
1.5 |
-33 |
-2.9 |
55.1 |
70 |
| ICU |
SeaStar Medical Holding Corporation |
41 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| IDYA |
IDEAYA Biosciences Inc |
2.8 B |
|
-23 |
|
0.46 |
4.6 |
0.00 |
-0.02 |
37.6 |
30 |
| IFRX |
InflaRx N V |
78 M |
|
-31 |
|
0.95 |
0.84 |
0.00 |
-0.04 |
32.6 |
26 |
| IGC |
IGC Pharma Inc |
23 M |
|
-103 |
|
4.2 |
2.7 |
0.00 |
-0.06 |
45.9 |
48 |
| IGMS |
IGM Biosciences Inc |
286 M |
|
-100 |
|
19 |
2.9 |
0.00 |
-0.21 |
51.3 |
62 |
| IKNA |
Ikena Oncology Inc |
-92 M |
|
-43 |
|
6.3 |
0.43 |
0.00 |
-0.13 |
36.9 |
33 |
| IKT |
Inhibikase Therapeutics Inc |
-4.6 M |
|
-95 |
|
1.8 |
0.69 |
0.00 |
-0.01 |
37.0 |
32 |
| IMAB |
I MAB |
-1.9 B |
|
-62 |
|
4.4 |
0.09 |
0.00 |
-0.05 |
35.5 |
31 |
| IMCR |
Immunocore Holdings plc |
2.7 B |
|
-15 |
|
22 |
8.3 |
-22 |
28 |
50.1 |
57 |
| IMMP |
Immutep Limited |
2.8 B |
|
-42 |
|
1.4 |
24 |
0.00 |
-0.04 |
45.0 |
42 |
| IMMX |
Immix Biopharma Inc |
35 M |
|
-78 |
|
|
2.7 |
0.00 |
|
64.9 |
96 |
| IMNM |
Immunome Inc |
939 M |
|
-150 |
|
5.8 |
48 |
-215 |
0.11 |
57.1 |
67 |
| IMNN |
Imunon Inc |
-10 M |
|
-93 |
|
9.6 |
0.42 |
0.00 |
-0.09 |
41.3 |
42 |
| IMRN |
Immuron Limited |
590 M |
|
-20 |
|
0.97 |
34 |
-108 |
-0.05 |
50.8 |
61 |
| IMRX |
Immuneering Corporation |
-5.9 M |
|
-53 |
|
4.9 |
0.83 |
0.00 |
-0.09 |
38.7 |
36 |
| IMTX |
Immatics N V |
638 M |
|
-46 |
|
6.6 |
4.0 |
-111 |
-0.18 |
54.5 |
70 |
| IMUX |
Immunic Inc |
73 M |
|
-131 |
|
4.6 |
2.1 |
0.00 |
-0.02 |
44.2 |
45 |
| IMVT |
Immunovant Inc |
3.8 B |
|
-44 |
|
0.04 |
6.6 |
0.00 |
-0.00 |
36.0 |
22 |
| INBX |
Inhibrx Inc |
1.6 B |
|
-475 |
|
483 |
38 |
0.00 |
-1.1 |
69.3 |
113 |
| INCY |
Incyte Corporation |
9.5 B |
22 |
12 |
|
1.00 |
2.5 |
16 |
0.11 |
13.1 |
3 |
| INDP |
Indaptus Therapeutics Inc |
4.3 M |
|
-84 |
|
1.4 |
1.4 |
0.00 |
-0.01 |
38.2 |
33 |
| INKT |
MiNK Therapeutics Inc |
23 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| INM |
InMed Pharmaceuticals Inc |
-6.3 M |
|
-46 |
|
9.1 |
0.16 |
-115 |
-0.18 |
45.7 |
44 |
| INMB |
INmune Bio Inc |
169 M |
|
-50 |
|
28 |
4.5 |
0.00 |
-0.90 |
53.5 |
67 |
| INO |
Inovio Pharmaceuticals Inc |
135 M |
|
-79 |
|
25 |
2.1 |
0.00 |
-0.24 |
49.6 |
59 |
| INSM |
Insmed Incorporated |
4.5 B |
|
|
|
|
|
-245 |
|
87.5 |
180 |
| INTS |
Intensity Therapeutics Inc |
54 M |
|
-261 |
|
1.2 |
5.2 |
0.00 |
-0.02 |
48.0 |
47 |
| INVA |
Innoviva Inc |
1.2 B |
6.7 |
28 |
|
66 |
1.4 |
57 |
3.2 |
18.0 |
7 |
| INZY |
Inozyme Pharma Inc |
209 M |
|
-54 |
|
33 |
2.5 |
0.00 |
-0.66 |
50.8 |
61 |
| IOBT |
IO Biotech Inc |
-33 M |
|
-63 |
|
1.9 |
0.81 |
0.00 |
-0.03 |
36.5 |
32 |
| IONS |
Ionis Pharmaceuticals Inc |
5.3 B |
|
-76 |
|
375 |
15 |
-46 |
-4.7 |
72.7 |
126 |
| IOVA |
Iovance Biotherapeutics Inc |
3.7 B |
|
-81 |
|
12 |
6.1 |
0.00 |
-0.21 |
52.7 |
63 |
| IPA |
ImmunoPrecise Antibodies Ltd |
46 M |
|
-25 |
|
28 |
0.77 |
-60 |
-3.8 |
52.3 |
64 |
| IPHA |
Innate Pharma S A |
147 M |
|
-71 |
|
70 |
3.4 |
-119 |
-1.3 |
65.6 |
101 |
| IPSC |
Century Therapeutics Inc |
187 M |
|
-56 |
|
26 |
1.6 |
0.00 |
-0.55 |
47.9 |
55 |
| IRON |
Disc Medicine Inc |
1.3 B |
|
-31 |
|
0.55 |
4.5 |
0.00 |
-0.03 |
38.8 |
32 |
| ITOS |
iTeos Therapeutics Inc |
-139 M |
|
-18 |
|
1.1 |
0.67 |
0.00 |
-0.06 |
31.6 |
25 |
| ITRM |
Iterum Therapeutics plc |
5.9 M |
|
-172 |
|
588 |
6.3 |
0.00 |
-0.66 |
64.9 |
100 |
| IVA |
Inventiva S A |
149 M |
|
-258 |
|
|
|
0.00 |
|
75.8 |
132 |
| IVVD |
Invivyd Inc |
102 M |
|
-54 |
|
1.00 |
1.5 |
0.00 |
-0.02 |
36.3 |
30 |
| JANX |
Janux Therapeutics Inc |
1.7 B |
|
-17 |
|
7.1 |
5.2 |
0.00 |
-0.49 |
46.4 |
50 |
| JAZZ |
Jazz Pharmaceuticals plc |
12 B |
20 |
12 |
|
155 |
2.1 |
10.0 |
5.3 |
25.7 |
16 |
| JSPR |
Jasper Therapeutics Inc |
311 M |
|
-112 |
|
3.6 |
3.7 |
0.00 |
-0.05 |
47.4 |
50 |
| KA |
Kineta Inc |
-182 K |
|
|
|
56 |
2.0 |
0.00 |
-0.08 |
55.2 |
74 |
| KALA |
KALA BIO Inc |
810 K |
|
-905 |
|
321 |
1.9 |
0.00 |
-1.1 |
61.5 |
90 |
| KALV |
KalVista Pharmaceuticals Inc |
431 M |
|
-79 |
|
8.4 |
4.6 |
0.00 |
-0.08 |
48.9 |
54 |
| KNSA |
Kiniksa Pharmaceuticals Ltd |
1.2 B |
98 |
3.4 |
|
2.8 |
3.2 |
5.2 |
0.92 |
20.2 |
9 |
| KNTE |
Kinnate Biopharma Inc |
-44 M |
|
-55 |
|
2.0 |
0.70 |
0.00 |
-0.03 |
35.5 |
30 |
| KOD |
Kodiak Sciences Inc |
18 M |
|
-69 |
|
27 |
0.92 |
0.00 |
-0.47 |
47.2 |
54 |
| KPRX |
Kiora Pharmaceuticals Inc |
-799 K |
0.76 |
-136 |
|
0.23 |
0.57 |
0.00 |
-0.00 |
22.0 |
3 |
| KPTI |
Karyopharm Therapeutics Inc |
276 M |
|
|
|
|
|
-97 |
|
86.1 |
175 |
| KRON |
Kronos Bio Inc |
-90 M |
|
-53 |
|
16 |
0.38 |
0.00 |
-0.39 |
41.8 |
43 |
| KROS |
Keros Therapeutics Inc |
2.0 B |
|
-50 |
|
4.3 |
6.2 |
0.00 |
-0.12 |
47.1 |
49 |
| KRRO |
Korro Bio Inc |
579 M |
|
|
|
55 |
|
0.00 |
|
72.5 |
115 |
| KRYS |
Krystal Biotech Inc |
4.2 B |
439 |
1.7 |
|
1.00 |
6.1 |
21 |
-0.09 |
26.1 |
8 |
| KTTA |
Pasithea Therapeutics Corp |
-12 M |
|
-44 |
|
1.4 |
0.25 |
0.00 |
-0.03 |
31.9 |
25 |
| KURA |
Kura Oncology Inc |
1.2 B |
|
-37 |
|
4.3 |
4.1 |
0.00 |
-0.14 |
44.2 |
45 |
| KYMR |
Kymera Therapeutics Inc |
2.1 B |
|
-33 |
|
21 |
5.6 |
-186 |
-0.82 |
60.4 |
89 |
| KZIA |
Kazia Therapeutics Limited |
599 M |
|
-134 |
|
14 |
0.48 |
0.00 |
-0.12 |
44.1 |
48 |
| KZR |
Kezar Life Sciences Inc |
-119 M |
|
-44 |
|
10.0 |
0.34 |
0.00 |
-0.23 |
38.8 |
37 |
| LABP |
Landos Biopharma Inc |
-21 M |
|
-51 |
|
|
0.57 |
0.00 |
|
56.7 |
69 |
| LBPH |
Longboard Pharmaceuticals Inc |
694 M |
|
-106 |
|
1.2 |
12 |
0.00 |
-0.01 |
47.4 |
45 |
| LCTX |
Lineage Cell Therapeutics Inc |
194 M |
|
-32 |
|
4.8 |
3.3 |
-240 |
-0.10 |
51.6 |
62 |
| LEGN |
Legend Biotech Corporation |
22 B |
|
-51 |
|
26 |
9.1 |
-181 |
-0.84 |
64.4 |
100 |
| LEXX |
Lexaria Bioscience Corp |
40 M |
|
-131 |
|
4.6 |
11 |
0.00 |
-0.03 |
51.0 |
56 |
| LGND |
Ligand Pharmaceuticals Incorporated |
1.1 B |
23 |
8.3 |
|
0.88 |
1.8 |
39 |
0.12 |
10.8 |
1 |
| LGVN |
Longeveron Inc |
8.0 M |
|
-157 |
|
30 |
1.7 |
0.00 |
-0.11 |
50.2 |
61 |
| LIFE |
aTyr Pharma Inc |
52 M |
|
-62 |
|
16 |
1.4 |
0.00 |
-0.45 |
46.4 |
52 |
| LIPO |
Lipella Pharmaceuticals Inc |
1.5 M |
|
-118 |
|
4.3 |
1.4 |
0.00 |
-0.04 |
42.8 |
43 |
| LIXT |
Lixte Biotechnology Holdings Inc |
3.6 M |
|
-100 |
|
|
3.6 |
0.00 |
|
67.5 |
105 |
| LPCN |
Lipocine Inc |
1.0 M |
|
-58 |
|
2.1 |
1.1 |
0.00 |
-0.04 |
37.6 |
34 |
| LPTX |
Leap Therapeutics Inc |
-14 M |
|
-136 |
|
0.44 |
0.94 |
0.00 |
-0.01 |
37.6 |
32 |
| LQDA |
Liquidia Corporation |
1.2 B |
|
-114 |
|
104 |
23 |
0.00 |
-1.2 |
65.1 |
98 |
| LRMR |
Larimar Therapeutics Inc |
467 M |
|
-38 |
|
6.8 |
4.6 |
0.00 |
-0.17 |
45.9 |
48 |
| LSTA |
Lisata Therapeutics Inc |
-25 M |
|
-36 |
|
0.64 |
0.52 |
0.00 |
-0.02 |
30.6 |
23 |
| LTRN |
Lantern Pharma Inc |
39 M |
|
-32 |
|
0.57 |
2.0 |
0.00 |
-0.02 |
34.6 |
27 |
| LUMO |
Lumos Pharma Inc |
-13 M |
|
-78 |
|
2.1 |
0.61 |
0.00 |
-0.02 |
36.5 |
32 |
| LVTX |
LAVA Therapeutics N V |
-15 M |
|
-68 |
|
11 |
1.5 |
0.00 |
0.90 |
37.9 |
31 |
| LXEO |
Lexeo Therapeutics Inc |
475 M |
|
-71 |
|
10.0 |
|
0.00 |
|
62.1 |
83 |
| LXRX |
Lexicon Pharmaceuticals Inc |
527 M |
|
-165 |
|
105 |
6.3 |
0.00 |
-0.57 |
62.7 |
93 |
| LYEL |
Lyell Immunopharma Inc |
23 M |
|
-31 |
|
9.6 |
0.77 |
0.00 |
-0.39 |
39.9 |
39 |
| LYRA |
Lyra Therapeutics Inc |
221 M |
|
-69 |
|
7.5 |
3.6 |
0.00 |
-0.11 |
47.6 |
52 |
| MACK |
Merrimack Pharmaceuticals Inc |
194 M |
|
-6.2 |
|
|
11 |
0.00 |
|
63.4 |
89 |
| MAIA |
MAIA Biotechnology Inc |
18 M |
|
-243 |
|
|
8.4 |
0.00 |
|
72.8 |
122 |
| MBIO |
Mustang Bio Inc |
7.1 M |
|
-222 |
|
2030 |
80 |
0.00 |
-0.05 |
63.7 |
99 |
| MBRX |
Moleculin Biotech Inc |
-8.4 M |
|
-56 |
|
1.7 |
0.44 |
0.00 |
-0.02 |
33.8 |
27 |
| MCRB |
Seres Therapeutics Inc |
208 M |
|
|
|
|
|
-90 |
|
86.0 |
174 |
| MDGL |
Madrigal Pharmaceuticals Inc |
4.8 B |
|
-123 |
|
28 |
13 |
0.00 |
-0.36 |
59.1 |
80 |
| MDWD |
MediWound Ltd |
105 M |
|
-71 |
|
17 |
4.4 |
-49 |
-1.00 |
61.1 |
89 |
| MDXG |
MiMedx Group |
1.2 B |
18 |
62 |
|
35 |
8.2 |
18 |
1.9 |
24.3 |
16 |
| MEIP |
MEI Pharma Inc |
-23 M |
1.2 |
36 |
|
20 |
0.42 |
27 |
-0.23 |
17.8 |
2 |
| MESO |
Mesoblast Limited |
2.4 B |
|
-14 |
|
23 |
4.6 |
0.00 |
-2.1 |
50.6 |
59 |
| MGNX |
MacroGenics Inc |
777 M |
|
-6.2 |
|
22 |
6.3 |
-15 |
-0.43 |
54.2 |
71 |
| MGTX |
MeiraGTx Holdings plc |
363 M |
|
-65 |
|
64 |
2.9 |
0.00 |
-0.85 |
54.9 |
71 |
| MGX |
Metagenomi Inc |
174 M |
|
|
|
20 |
|
-167 |
|
78.6 |
141 |
| MIRM |
Mirum Pharmaceuticals Inc |
1.3 B |
|
-83 |
|
123 |
5.1 |
-87 |
-4.3 |
70.2 |
116 |
| MIST |
Milestone Pharmaceuticals Inc |
38 M |
|
-112 |
|
179 |
2.2 |
0.00 |
-1.00 |
59.0 |
82 |
| MLEC |
Moolec Science SA |
|
|
-69 |
|
|
8.4 |
-208 |
|
77.9 |
144 |
| MLTX |
MoonLake Immunotherapeutics |
2.7 B |
|
-15 |
|
0.72 |
6.2 |
0.00 |
-0.09 |
40.6 |
36 |
| MLYS |
Mineralys Therapeutics Inc |
300 M |
|
-29 |
|
|
2.1 |
0.00 |
|
58.8 |
75 |
| MNKD |
MannKind Corporation |
1.3 B |
|
|
|
|
|
-6.0 |
|
83.0 |
161 |
| MNMD |
Mind Medicine (MindMed) Inc |
319 M |
|
-83 |
|
18 |
5.1 |
0.00 |
-0.22 |
53.1 |
65 |
| MNOV |
MediciNova Inc |
14 M |
|
-12 |
|
1.00 |
1.00 |
0.00 |
-0.08 |
32.8 |
27 |
| MNPR |
Monopar Therapeutics Inc |
2.8 M |
|
-99 |
|
|
1.6 |
0.00 |
|
63.3 |
91 |
| MOLN |
Molecular Partners AG |
-56 M |
|
-30 |
|
2.1 |
0.72 |
0.00 |
-0.06 |
33.8 |
28 |
| MOR |
MorphoSys AG |
260 M |
|
-183 |
|
526 |
13 |
-79 |
-0.87 |
74.7 |
132 |
| MORF |
Morphic Holding Inc |
994 M |
|
-29 |
|
0.34 |
2.4 |
0.00 |
-0.02 |
34.8 |
27 |
| MREO |
Mereo BioPharma Group plc |
1.9 B |
|
-40 |
|
16 |
6.6 |
0.00 |
-0.28 |
50.5 |
59 |
| MRKR |
Marker Therapeutics Inc |
22 M |
|
-124 |
|
|
2.3 |
-109 |
|
74.1 |
126 |
| MRNA |
Moderna Inc |
33 B |
|
-28 |
|
9.0 |
2.9 |
-68 |
-0.40 |
52.0 |
66 |
| MRNS |
Marinus Pharmaceuticals Inc |
468 M |
|
-213 |
|
658 |
30 |
0.00 |
-0.94 |
68.3 |
110 |
| MRSN |
Mersana Therapeutics Inc |
426 M |
|
-266 |
|
91 |
16 |
0.00 |
-0.20 |
63.1 |
94 |
| MRUS |
Merus N V |
2.3 B |
|
-51 |
|
3.4 |
7.3 |
0.00 |
-0.09 |
46.8 |
48 |
| MRVI |
Maravai LifeSciences Holdings Inc |
1.5 B |
|
-16 |
|
77 |
2.5 |
-41 |
4.8 |
48.6 |
47 |
| MTEM |
Molecular Templates Inc |
6.6 M |
|
-478 |
|
188 |
1.4 |
-49 |
-0.23 |
63.6 |
91 |
| MTNB |
Matinas Biopharma Holdings Inc |
47 M |
|
-68 |
|
16 |
2.7 |
0.00 |
-0.25 |
49.1 |
57 |
| MURA |
Mural Oncology plc |
|
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| MYMD |
MyMD Pharmaceuticals Inc |
-2.7 M |
|
-31 |
|
0.58 |
0.29 |
0.00 |
-0.01 |
28.3 |
19 |
| NAMS |
NewAmsterdam Pharma Company N V |
1.6 B |
|
-49 |
|
0.02 |
6.3 |
0.00 |
-0.00 |
36.3 |
22 |
| NAUT |
Nautilus Biotechnology Inc |
186 M |
|
-21 |
|
13 |
1.2 |
0.00 |
-0.67 |
41.9 |
42 |
| NBSE |
NeuBase Therapeutics Inc |
-3.4 M |
|
-93 |
|
58 |
0.42 |
0.00 |
-0.22 |
47.3 |
53 |
| NBTX |
Nanobiotix S A |
251 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| NCNA |
NuCana plc |
136 K |
|
-94 |
|
2.1 |
0.80 |
0.00 |
-0.01 |
37.6 |
33 |
| NERV |
Minerva Neurosciences |
60 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| NEXI |
NexImmune Inc |
-2.3 M |
|
-156 |
|
7.3 |
0.74 |
0.00 |
-0.02 |
41.8 |
42 |
| NGM |
NGM Biopharmaceuticals Inc |
-14 M |
|
-69 |
|
|
0.87 |
0.00 |
|
59.7 |
79 |
| NGNE |
Neurogene Inc |
397 M |
|
-25 |
|
8.0 |
|
0.00 |
|
57.0 |
72 |
| NKGN |
NKGen Biotech Inc |
58 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| NKTR |
Nektar Therapeutics |
-26 M |
|
-110 |
|
89 |
1.3 |
0.00 |
-0.61 |
54.0 |
69 |
| NKTX |
Nkarta Inc |
414 M |
|
-35 |
|
30 |
2.0 |
0.00 |
-1.3 |
48.7 |
56 |
| NLSP |
NLS Pharmaceutics Ltd |
7.1 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| NMRA |
Neumora Therapeutics Inc |
1.8 B |
|
-54 |
|
1.1 |
4.8 |
0.00 |
-0.03 |
42.5 |
39 |
| NNVC |
NanoViricides Inc |
8.3 M |
|
-57 |
|
|
1.1 |
0.00 |
|
59.4 |
78 |
| NRBO |
NeuroBo Pharmaceuticals Inc |
-5.7 M |
|
-86 |
|
1.00 |
0.92 |
0.00 |
-0.02 |
37.3 |
32 |
| NRIX |
Nurix Therapeutics Inc |
366 M |
|
-57 |
|
15 |
3.1 |
-186 |
-0.38 |
58.3 |
80 |
| NRSN |
NeuroSense Therapeutics Ltd |
10 M |
|
-300 |
|
|
|
0.00 |
|
76.0 |
132 |
| NRXP |
NRX Pharmaceuticals Inc |
41 M |
|
-682 |
|
|
|
0.00 |
|
76.7 |
135 |
| NRXS |
Neuraxis Inc |
17 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| NTBL |
Notable Labs Ltd |
71 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| NTLA |
Intellia Therapeutics Inc |
1.9 B |
|
-42 |
|
10.0 |
2.4 |
0.00 |
-0.29 |
45.2 |
48 |
| NTRB |
Nutriband Inc |
20 M |
|
-68 |
|
39 |
3.4 |
-253 |
-0.62 |
63.3 |
94 |
| NUVB |
Nuvation Bio Inc |
-169 M |
|
-12 |
|
0.66 |
0.72 |
0.00 |
-0.06 |
30.9 |
24 |
| NUVL |
Nuvalent Inc |
4.3 B |
|
-21 |
|
|
7.1 |
0.00 |
|
63.6 |
90 |
| NVAX |
Novavax Inc |
403 M |
|
|
|
|
|
-55 |
|
85.2 |
171 |
| NVCT |
Nuvectis Pharma Inc |
137 M |
|
-168 |
|
|
12 |
0.00 |
|
72.8 |
122 |
| NVO |
Novo Nordisk A/S |
582 B |
48 |
88 |
7.1 |
25 |
5.5 |
36 |
0.25 |
22.0 |
12 |
| NXTC |
NextCure Inc |
-72 M |
|
-42 |
|
5.3 |
0.31 |
0.00 |
-0.13 |
36.0 |
32 |
| OABI |
OmniAb Inc |
542 M |
|
-10.0 |
|
8.1 |
1.9 |
-45 |
6.1 |
41.4 |
34 |
| OBIO |
Orchestra BioMed Holdings Inc |
92 M |
|
-65 |
|
14 |
2.4 |
0.00 |
-0.26 |
48.0 |
54 |
| OCEA |
Ocean Biomedical Inc |
165 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| OCGN |
Ocugen Inc |
235 M |
|
-98 |
|
11 |
4.8 |
0.00 |
-0.10 |
51.1 |
60 |
| OCS |
Oculis Holding AG |
398 M |
|
|
|
0.65 |
4.6 |
0.00 |
-0.01 |
48.3 |
46 |
| OCUL |
Ocular Therapeutix Inc |
1.3 B |
|
-127 |
|
91 |
12 |
-138 |
-1.2 |
72.9 |
126 |
| OCUP |
Ocuphire Pharma Inc |
-3.1 M |
|
-20 |
|
|
0.92 |
-52 |
|
62.0 |
81 |
| OGEN |
Oragenics Inc |
-7.6 K |
|
-93 |
|
8.0 |
0.74 |
0.00 |
-0.06 |
41.7 |
42 |
| OKYO |
OKYO Pharma Limited |
36 M |
|
-2968 |
|
|
|
0.00 |
|
77.2 |
137 |
| OLMA |
Olema Pharmaceuticals Inc |
386 M |
|
-42 |
|
0.95 |
2.5 |
0.00 |
-0.03 |
37.7 |
32 |
| OMER |
Omeros Corporation |
382 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| OMGA |
Omega Therapeutics Inc |
231 M |
|
-103 |
|
172 |
2.5 |
0.00 |
-1.3 |
59.6 |
84 |
| ONCT |
Oncternal Therapeutics Inc |
-11 M |
|
-86 |
|
1.1 |
0.77 |
0.00 |
-0.01 |
36.2 |
30 |
| ONCY |
Oncolytics Biotech Inc |
43 M |
|
-102 |
|
1.5 |
2.8 |
0.00 |
-0.01 |
42.5 |
39 |
| ONTX |
Onconova Therapeutics Inc |
-7.9 M |
|
-84 |
|
|
1.2 |
0.00 |
|
61.6 |
86 |
| ONVO |
Organovo Holdings Inc |
6.7 M |
|
-134 |
|
24 |
1.7 |
0.00 |
-0.09 |
48.6 |
57 |
| OPT |
Opthea Limited |
2.3 B |
|
-3383 |
|
|
|
0.00 |
|
77.2 |
137 |
| ORGS |
Orgenesis Inc |
50 M |
|
-102 |
|
175 |
2.2 |
-90 |
-0.87 |
66.2 |
100 |
| ORIC |
Oric Pharmaceuticals Inc |
767 M |
|
-45 |
|
4.6 |
3.5 |
0.00 |
-0.12 |
44.3 |
45 |
| ORMP |
Oramed Pharmaceuticals Inc |
3.3 M |
20 |
3.2 |
|
31 |
0.70 |
412 |
-5.0 |
27.1 |
8 |
| OTLK |
Outlook Therapeutics Inc |
123 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| OVID |
Ovid Therapeutics Inc |
105 M |
|
-47 |
|
18 |
2.2 |
0.00 |
-0.35 |
46.9 |
52 |
| PALI |
Palisade Bio Inc |
-11 M |
1.2 |
-98 |
|
3.5 |
0.24 |
0.00 |
-0.04 |
28.0 |
12 |
| PASG |
Passage Bio Inc |
-10 M |
|
-65 |
|
23 |
0.69 |
0.00 |
-0.34 |
44.8 |
49 |
| PBYI |
Puma Biotechnology Inc |
223 M |
9.6 |
57 |
|
208 |
3.8 |
9.2 |
4.1 |
27.1 |
20 |
| PCSA |
Processa Pharmaceuticals Inc |
-3.9 M |
|
-178 |
|
2.4 |
0.39 |
0.00 |
-0.02 |
38.6 |
36 |
| PCVX |
Vaxcyte Inc |
6.3 B |
|
-36 |
|
2.4 |
5.2 |
0.00 |
-0.10 |
43.7 |
43 |
| PDSB |
PDS Biotechnology Corporation |
115 M |
|
-143 |
|
96 |
5.9 |
0.00 |
-0.72 |
62.3 |
91 |
| PEPG |
PepGen Inc |
362 M |
|
-54 |
|
18 |
3.1 |
0.00 |
-0.29 |
49.1 |
57 |
| PGEN |
Precigen Inc |
303 M |
|
-78 |
|
6.0 |
3.0 |
0.00 |
-0.11 |
46.7 |
50 |
| PHAT |
Phathom Pharmaceuticals Inc |
569 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| PHGE |
BiomX Inc |
11 M |
|
-153 |
|
198 |
2.1 |
0.00 |
-0.73 |
58.9 |
83 |
| PHIO |
Phio Pharmaceuticals Corp |
-5.9 M |
|
-112 |
|
0.97 |
0.31 |
0.00 |
-0.01 |
35.1 |
29 |
| PHVS |
Pharvaris N V |
907 M |
|
-63 |
|
0.19 |
7.0 |
0.00 |
-0.00 |
38.2 |
25 |
| PLRX |
Pliant Therapeutics Inc |
403 M |
|
-41 |
|
2.4 |
1.9 |
0.00 |
-0.10 |
39.2 |
36 |
| PLUR |
Pluri Inc |
41 M |
|
-154 |
|
460 |
8.9 |
0.00 |
-1.6 |
66.9 |
105 |
| PLX |
Protalix BioTherapeutics Inc |
77 M |
14 |
72 |
|
78 |
2.8 |
12 |
-19 |
33.9 |
17 |
| PMCB |
PharmaCyte Biotech Inc |
-20 M |
|
-1.7 |
|
|
0.58 |
0.00 |
|
52.2 |
53 |
| PMN |
ProMIS Neurosciences Inc |
20 M |
|
-451 |
|
|
5.4 |
0.00 |
|
72.1 |
120 |
| PMVP |
PMV Pharmaceuticals Inc |
-103 M |
|
-29 |
|
5.9 |
0.39 |
0.00 |
-0.24 |
36.1 |
32 |
| PPBT |
Purple Biotech Ltd |
173 M |
|
-49 |
|
1.00 |
5.2 |
0.00 |
-0.02 |
41.7 |
37 |
| PRAX |
Praxis Precision Medicines Inc |
633 M |
|
-169 |
|
3.6 |
6.8 |
0.00 |
-0.02 |
49.9 |
53 |
| PRLD |
Prelude Therapeutics Incorporated |
50 M |
|
-56 |
|
7.1 |
1.1 |
0.00 |
-0.16 |
41.6 |
42 |
| PRME |
Prime Medicine Inc |
711 M |
|
-88 |
|
10.0 |
5.0 |
0.00 |
-0.08 |
50.2 |
57 |
| PROK |
ProKidney Corp |
1.2 B |
|
-29 |
|
0.65 |
|
0.00 |
|
53.4 |
61 |
| PRQR |
ProQR Therapeutics N V |
105 M |
|
-51 |
|
47 |
4.9 |
0.00 |
0.92 |
45.6 |
48 |
| PRTA |
Prothena Corporation |
741 M |
|
-24 |
|
2.1 |
2.4 |
-160 |
-0.09 |
47.2 |
52 |
| PRTC |
PureTech Health plc |
7.6 B |
|
-7.2 |
|
25 |
15 |
0.00 |
-0.83 |
52.0 |
62 |
| PRTG |
Portage Biotech Inc |
5.1 M |
|
-145 |
|
0.88 |
0.34 |
0.00 |
-0.02 |
36.4 |
32 |
| PSTV |
PLUS THERAPEUTICS Inc |
3.5 M |
|
-522 |
|
|
|
-271 |
|
86.0 |
175 |
| PSTX |
Poseida Therapeutics Inc |
154 M |
|
-84 |
|
82 |
2.7 |
-190 |
-0.93 |
65.9 |
101 |
| PTCT |
PTC Therapeutics Inc |
3.7 B |
|
|
|
|
|
-66 |
|
85.4 |
172 |
| PTGX |
Protagonist Therapeutics Inc |
1.3 B |
|
-28 |
|
0.34 |
4.9 |
-131 |
-0.02 |
46.5 |
49 |
| PTIX |
Protagenic Therapeutics Inc |
891 K |
|
-68 |
|
10.0 |
1.4 |
0.00 |
-0.15 |
44.0 |
46 |
| PTN |
Palatin Technologies Inc |
17 M |
|
-1413 |
|
|
|
0.00 |
|
77.1 |
136 |
| PULM |
Pulmatrix Inc |
-6.8 M |
|
-59 |
|
43 |
0.30 |
-238 |
-0.45 |
54.0 |
61 |
| PXMD |
PaxMedica Inc |
31 K |
|
-1046 |
|
|
1.4 |
0.00 |
|
66.3 |
102 |
| PYPD |
PolyPid Ltd |
31 M |
|
-1278 |
|
|
|
0.00 |
|
77.0 |
136 |
| PYXS |
Pyxis Oncology Inc |
117 M |
|
-57 |
|
15 |
1.7 |
0.00 |
-0.30 |
46.0 |
51 |
| QLGN |
Qualigen Therapeutics Inc |
591 K |
|
-290 |
|
|
|
0.00 |
|
75.9 |
132 |
| QNCX |
Quince Therapeutics Inc |
-31 M |
|
-29 |
|
0.07 |
0.53 |
0.00 |
-0.00 |
24.3 |
9 |
| QNRX |
Quoin Pharmaceuticals Ltd |
-3.9 M |
|
-132 |
|
62 |
0.16 |
0.00 |
-0.45 |
48.8 |
57 |
| QSI |
Quantum Si Incorporated |
26 M |
|
-30 |
|
5.6 |
0.99 |
0.00 |
-0.16 |
37.9 |
35 |
| QURE |
uniQure N V |
160 M |
|
-90 |
|
256 |
1.2 |
0.00 |
-3.7 |
57.2 |
76 |
| RANI |
Rani Therapeutics Holdings Inc |
79 M |
|
-117 |
|
86 |
5.2 |
0.00 |
-0.57 |
60.5 |
86 |
| RAPT |
RAPT Therapeutics Inc |
149 M |
|
-59 |
|
4.7 |
2.0 |
0.00 |
-0.07 |
42.0 |
41 |
| RARE |
Ultragenyx Pharmaceutical Inc |
3.3 B |
|
-193 |
|
15 |
14 |
-139 |
-0.09 |
64.8 |
95 |
| RCKT |
Rocket Pharmaceuticals Inc |
2.1 B |
|
-50 |
|
5.1 |
4.9 |
0.00 |
-0.13 |
46.6 |
49 |
| RCUS |
Arcus Biosciences Inc |
934 M |
|
-54 |
|
26 |
2.8 |
-262 |
-0.40 |
59.5 |
83 |
| REGN |
Regeneron Pharmaceuticals Inc |
95 B |
27 |
16 |
|
10.0 |
4.0 |
30 |
0.59 |
19.0 |
9 |
| RENB |
Renovaro Inc |
468 M |
|
-74 |
|
18 |
4.9 |
0.00 |
-0.70 |
54.3 |
68 |
| REPL |
Replimune Group Inc |
117 M |
|
-41 |
|
17 |
1.2 |
0.00 |
-0.44 |
43.9 |
46 |
| REVB |
Revelation Biosciences Inc |
-14 M |
|
15 |
|
|
0.05 |
0.00 |
|
48.2 |
40 |
| RGLS |
Regulus Therapeutics Inc |
22 M |
|
-84 |
|
14 |
1.7 |
0.00 |
-0.15 |
46.5 |
52 |
| RGNX |
REGENXBIO Inc |
903 M |
|
-63 |
|
58 |
3.2 |
-291 |
-0.84 |
64.5 |
97 |
| RIGL |
Rigel Pharmaceuticals Inc |
287 M |
|
|
|
|
|
-21 |
|
84.0 |
165 |
| RLAY |
Relay Therapeutics Inc |
325 M |
|
-40 |
|
7.1 |
1.3 |
0.00 |
-0.18 |
40.4 |
39 |
| RLMD |
Relmada Therapeutics Inc |
66 M |
|
-87 |
|
|
1.9 |
0.00 |
|
63.4 |
91 |
| RLYB |
Rallybio Corporation |
-49 M |
|
-54 |
|
0.37 |
0.57 |
0.00 |
-0.01 |
31.8 |
24 |
| RNA |
Avidity Biosciences Inc |
1.3 B |
|
-39 |
|
2.0 |
3.8 |
0.00 |
-0.08 |
42.0 |
40 |
| RNAC |
Cartesian Therapeutics Inc |
351 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| RNAZ |
TransCode Therapeutics Inc |
-6.5 M |
|
-308 |
|
13 |
0.04 |
0.00 |
-0.04 |
42.2 |
44 |
| RNXT |
RenovoRx Inc |
12 M |
|
-224 |
|
|
1429 |
0.00 |
|
74.4 |
127 |
| ROIV |
Roivant Sciences Ltd |
2.3 B |
1.9 |
105 |
|
7.7 |
1.3 |
3624 |
-0.61 |
19.7 |
3 |
| RPHM |
Reneo Pharmaceuticals Inc |
-70 M |
|
-59 |
|
0.99 |
0.49 |
0.00 |
-0.02 |
33.5 |
27 |
| RPRX |
Royalty Pharma plc |
23 B |
11 |
17 |
2.7 |
60 |
2.1 |
48 |
2.1 |
19.8 |
11 |
| RPTX |
Repare Therapeutics Inc |
818 K |
|
-38 |
|
1.6 |
1.00 |
-183 |
-0.03 |
43.5 |
40 |
| RVMD |
Revolution Medicines Inc |
3.3 B |
|
-34 |
|
4.8 |
2.8 |
0.00 |
-0.25 |
43.3 |
44 |
| RVNC |
Revance Therapeutics Inc |
659 M |
|
|
|
|
|
-138 |
|
86.7 |
177 |
| RVPH |
Reviva Pharmaceuticals Holdings Inc |
60 M |
|
-636 |
|
|
|
0.00 |
|
76.6 |
135 |
| RXRX |
Recursion Pharmaceuticals Inc |
2.2 B |
|
-69 |
|
10.0 |
5.4 |
0.00 |
-0.18 |
50.8 |
59 |
| RYTM |
Rhythm Pharmaceuticals Inc |
2.2 B |
|
-85 |
|
63 |
13 |
-238 |
-0.79 |
70.2 |
117 |
| RZLT |
Rezolute Inc |
-15 M |
|
-48 |
|
2.7 |
0.82 |
0.00 |
-0.05 |
36.2 |
32 |
| SABS |
SAB Biotherapeutics Inc |
27 M |
|
-118 |
|
30 |
1.6 |
0.00 |
-0.35 |
51.2 |
63 |
| SAGE |
Sage Therapeutics Inc |
411 M |
|
-52 |
|
0.65 |
1.4 |
0.00 |
-0.01 |
34.7 |
27 |
| SANA |
Sana Biotechnology Inc |
1.8 B |
|
-72 |
|
36 |
6.0 |
0.00 |
-0.41 |
56.0 |
73 |
| SAVA |
Cassava Sciences Inc |
829 M |
|
-53 |
|
|
6.8 |
0.00 |
|
66.8 |
101 |
| SCNI |
Scinai Immunotherapeutics Ltd |
901 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| SEEL |
Seelos Therapeutics Inc |
20 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| SEER |
Seer Inc |
-164 M |
|
-20 |
|
7.1 |
0.31 |
0.00 |
-0.48 |
36.5 |
34 |
| SGMO |
Sangamo Therapeutics Inc |
95 M |
|
-136 |
|
45 |
1.7 |
-146 |
-0.17 |
60.1 |
80 |
| SGMT |
Sagimet Biosciences Inc |
835 K |
|
|
|
0.10 |
1.00 |
0.00 |
-0.00 |
36.9 |
26 |
| SILO |
Silo Pharma Inc |
-3.5 M |
|
-43 |
|
|
0.71 |
0.00 |
|
56.5 |
68 |
| SLDB |
Solid Biosciences Inc |
460 M |
|
-56 |
|
20 |
2.4 |
0.00 |
-0.28 |
48.1 |
55 |
| SLGL |
Sol Gel Technologies Ltd |
-9.0 M |
|
-67 |
|
4.3 |
0.71 |
0.00 |
-0.09 |
39.3 |
38 |
| SLN |
Silence Therapeutics Plc |
3.2 B |
|
-221 |
|
1.6 |
54 |
-170 |
-0.01 |
59.2 |
73 |
| SLNO |
Soleno Therapeutics Inc |
1.2 B |
|
-46 |
|
0.26 |
8.8 |
0.00 |
-0.02 |
41.9 |
35 |
| SLRN |
ACELYRIN |
-12 M |
|
|
|
0.20 |
1.1 |
0.00 |
-0.01 |
41.3 |
37 |
| SLRX |
Salarius Pharmaceuticals Inc |
-4.5 M |
|
-158 |
|
7.5 |
0.43 |
0.00 |
-0.03 |
41.1 |
41 |
| SLS |
SELLAS Life Sciences Group Inc |
30 M |
|
-874 |
|
|
|
0.00 |
|
76.8 |
136 |
| SMMT |
Summit Therapeutics Inc |
2.5 B |
|
-601 |
|
136 |
32 |
0.00 |
-1.4 |
68.6 |
109 |
| SNDX |
Syndax Pharmaceuticals Inc |
1.3 B |
|
-40 |
|
0.29 |
3.4 |
0.00 |
-0.01 |
37.2 |
29 |
| SNGX |
Soligenix Inc |
1.6 M |
|
-23783 |
|
138 |
2.6 |
0.00 |
-0.41 |
61.0 |
89 |
| SNSE |
Sensei Biotherapeutics Inc |
-33 M |
|
-40 |
|
9.6 |
0.41 |
0.00 |
-0.19 |
38.1 |
35 |
| SNTI |
Senti Biosciences Inc |
16 M |
|
-79 |
|
44 |
0.23 |
0.00 |
-0.69 |
46.9 |
53 |
| SONN |
Sonnet BioTherapeutics Holdings Inc |
3.9 M |
|
|
|
7.3 |
2.6 |
0.00 |
-0.01 |
49.2 |
55 |
| SPRB |
Spruce Biosciences Inc |
-61 M |
|
-66 |
|
5.7 |
0.40 |
0.00 |
-0.09 |
38.3 |
36 |
| SPRC |
SciSparc Ltd |
1.2 M |
0.00 |
4.8 |
|
|
0.15 |
8.7 |
|
34.2 |
9 |
| SPRO |
Spero Therapeutics Inc |
25 M |
4.1 |
24 |
|
5.2 |
0.88 |
21 |
-0.17 |
16.9 |
3 |
| SPRY |
ARS Pharmaceuticals Inc |
571 M |
|
-46 |
|
0.14 |
3.4 |
0.00 |
-0.01 |
37.6 |
29 |
| SRPT |
Sarepta Therapeutics Inc |
11 B |
|
-86 |
|
162 |
13 |
-43 |
-2.8 |
71.9 |
123 |
| SRRK |
Scholar Rock Holding Corporation |
962 M |
|
-68 |
|
27 |
5.1 |
0.00 |
-0.43 |
54.3 |
68 |
| SRZN |
Surrozen Inc |
-13 M |
|
-56 |
|
8.7 |
0.59 |
-279 |
-0.12 |
49.1 |
51 |
| STOK |
Stoke Therapeutics Inc |
48 M |
|
-54 |
|
1.9 |
1.5 |
0.00 |
-0.04 |
38.0 |
34 |
| STRO |
Sutro Biopharma Inc |
-101 M |
|
-100 |
|
33 |
1.9 |
0.00 |
-0.26 |
50.9 |
62 |
| STTK |
Shattuck Labs Inc |
270 M |
|
-54 |
|
2.9 |
2.7 |
0.00 |
-0.05 |
41.8 |
40 |
| SVRA |
Savara Inc |
535 M |
|
-44 |
|
19 |
4.8 |
0.00 |
-0.52 |
50.9 |
60 |
| SWTX |
SpringWorks Therapeutics Inc |
3.1 B |
|
-54 |
|
1.1 |
5.7 |
0.00 |
-0.03 |
43.3 |
40 |
| SYBX |
Synlogic Inc |
1.1 M |
|
-82 |
|
41 |
0.19 |
0.00 |
-0.31 |
45.4 |
49 |
| SYRE |
Spyre Therapeutics Inc |
1.2 B |
|
-289 |
|
|
|
0.00 |
|
75.9 |
132 |
| SYRS |
Syros Pharmaceuticals Inc |
81 M |
7.3 |
-126 |
|
172 |
3.6 |
0.00 |
-0.51 |
50.9 |
58 |
| TARA |
Protara Therapeutics Inc |
-14 M |
|
-47 |
|
8.0 |
0.67 |
0.00 |
-0.15 |
39.2 |
37 |
| TARS |
Tarsus Pharmaceuticals Inc |
883 M |
|
-69 |
|
16 |
5.5 |
0.00 |
-0.27 |
52.6 |
64 |
| TBPH |
Theravance Biopharma Inc |
373 M |
|
-16 |
|
23 |
2.0 |
-96 |
-1.8 |
54.4 |
72 |
| TCBP |
TC BioPharm (Holdings) plc |
9.0 M |
|
-102 |
|
122 |
0.21 |
-54 |
-0.20 |
55.6 |
64 |
| TCON |
TRACON Pharmaceuticals Inc |
10 M |
|
|
|
|
|
-29 |
|
84.3 |
167 |
| TCRT |
Alaunos Therapeutics Inc |
18 M |
|
-158 |
|
8.4 |
2.1 |
0.00 |
-0.04 |
46.9 |
51 |
| TCRX |
TScan Therapeutics Inc |
234 M |
|
-71 |
|
61 |
2.2 |
0.00 |
-1.5 |
54.9 |
71 |
| TECH |
Bio Techne Corp |
12 B |
50 |
11 |
0.45 |
28 |
5.7 |
19 |
2.0 |
25.4 |
16 |
| TELO |
Telomir Pharmaceuticals Inc |
333 M |
|
|
|
120 |
|
0.00 |
|
74.7 |
125 |
| TENX |
Tenax Therapeutics Inc |
-9.8 M |
|
-92 |
|
1.5 |
0.10 |
0.00 |
-0.02 |
34.8 |
30 |
| TERN |
Terns Pharmaceuticals Inc |
126 M |
|
-33 |
|
0.24 |
1.5 |
0.00 |
-0.01 |
32.3 |
23 |
| TFFP |
TFF Pharmaceuticals Inc |
11 M |
|
-150 |
|
0.99 |
1.5 |
0.00 |
-0.01 |
40.0 |
36 |
| TGTX |
TG Therapeutics Inc |
2.1 B |
170 |
11 |
|
69 |
13 |
5.4 |
-3.5 |
42.3 |
34 |
| THAR |
Tharimmune Inc |
-6.3 M |
|
-127 |
|
|
0.51 |
0.00 |
|
60.7 |
84 |
| THRD |
Third Harmonic Bio Inc |
98 M |
11 |
-12 |
|
1.5 |
1.3 |
0.00 |
-0.17 |
26.0 |
15 |
| THTX |
Theratechnologies Inc |
73 M |
|
|
|
|
|
-29 |
|
84.3 |
167 |
| TIL |
Instil Bio Inc |
-18 M |
|
-61 |
|
36 |
0.34 |
0.00 |
-0.82 |
45.7 |
50 |
| TLSA |
Tiziana Life Sciences Ltd |
43 M |
|
-90 |
|
2.7 |
3.7 |
0.00 |
-0.02 |
44.8 |
44 |
| TNGX |
Tango Therapeutics Inc |
572 M |
|
-40 |
|
15 |
3.3 |
-278 |
-0.33 |
57.1 |
78 |
| TNXP |
Tonix Pharmaceuticals Holding Corp |
2.5 M |
|
-69 |
|
0.95 |
0.05 |
0.00 |
-0.01 |
31.9 |
25 |
| TNYA |
Tenaya Therapeutics Inc |
263 M |
|
-64 |
|
8.9 |
2.2 |
0.00 |
-0.12 |
45.1 |
48 |
| TOVX |
Theriva Biologics Inc |
-19 M |
|
-37 |
|
5.1 |
0.18 |
0.00 |
-0.12 |
34.7 |
30 |
| TPST |
Tempest Therapeutics Inc |
64 M |
|
-131 |
|
77 |
3.1 |
0.00 |
-0.76 |
58.6 |
81 |
| TRDA |
Entrada Therapeutics Inc |
127 M |
|
-2.9 |
|
28 |
1.7 |
-5.2 |
0.49 |
39.1 |
26 |
| TRML |
Tourmaline Bio Inc |
840 M |
|
|
|
0.56 |
|
0.00 |
|
63.9 |
77 |
| TRVI |
Trevi Therapeutics Inc |
133 M |
|
-26 |
|
1.6 |
2.5 |
0.00 |
-0.04 |
37.2 |
32 |
| TRVN |
Trevena Inc |
8.7 M |
|
-242 |
|
995 |
2.3 |
0.00 |
-0.94 |
61.8 |
91 |
| TSBX |
Turnstone Biologics Corp |
-33 M |
|
|
|
3.2 |
0.63 |
-176 |
-0.05 |
52.9 |
57 |
| TSHA |
Taysha Gene Therapies Inc |
336 M |
|
-294 |
|
79 |
5.6 |
0.00 |
-0.81 |
63.0 |
93 |
| TTNP |
Titan Pharmaceuticals Inc |
-2.0 M |
|
-105 |
|
7.3 |
0.68 |
0.00 |
-0.09 |
42.3 |
44 |
| TVGN |
Tevogen Bio Holdings Inc |
203 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| TVTX |
Travere Therapeutics Inc |
407 M |
|
-308 |
|
201 |
2.8 |
-76 |
-1.4 |
70.3 |
114 |
| TYRA |
Tyra Biosciences Inc |
649 M |
|
-29 |
|
3.2 |
3.4 |
0.00 |
-0.13 |
41.7 |
40 |
| UBX |
Unity Biotechnology Inc |
3.8 M |
|
-91 |
|
76 |
0.61 |
0.00 |
-0.70 |
50.7 |
61 |
| UNCY |
Unicycive Therapeutics Inc |
35 M |
|
-696 |
|
25 |
14 |
0.00 |
-0.04 |
57.7 |
76 |
| URGN |
UroGen Pharma Ltd |
476 M |
|
|
|
|
|
-123 |
|
86.5 |
176 |
| UTHR |
United Therapeutics Corporation |
9.0 B |
12 |
18 |
|
12 |
1.9 |
42 |
0.75 |
14.4 |
5 |
| VALN |
Valneva SE |
1.1 B |
|
-70 |
|
123 |
6.8 |
-50 |
-1.00 |
68.1 |
110 |
| VANI |
Vivani Medical Inc |
100 M |
|
-69 |
|
80 |
3.9 |
0.00 |
-0.83 |
57.4 |
77 |
| VAXX |
Vaxxinity Inc |
64 M |
|
-126 |
|
56 |
3.9 |
0.00 |
-0.22 |
56.5 |
76 |
| VBIV |
VBI Vaccines Inc |
31 M |
|
-219 |
|
265 |
0.66 |
0.00 |
-0.78 |
55.9 |
74 |
| VCEL |
Vericel Corporation |
2.2 B |
|
-1.5 |
|
38 |
9.7 |
-1.6 |
2.5 |
47.4 |
49 |
| VCNX |
Vaccinex Inc |
7.6 M |
|
-1797 |
|
|
|
0.00 |
|
77.1 |
137 |
| VCYT |
Veracyte Inc |
1.4 B |
|
-7.0 |
|
1.2 |
1.5 |
-20 |
0.29 |
33.7 |
18 |
| VERA |
Vera Therapeutics Inc |
1.8 B |
|
-89 |
|
23 |
15 |
0.00 |
-0.33 |
57.1 |
74 |
| VERU |
Veru Inc |
61 M |
|
-188 |
|
81 |
3.1 |
0.00 |
-0.16 |
57.1 |
78 |
| VERV |
Verve Therapeutics Inc |
539 M |
|
-34 |
|
12 |
1.8 |
0.00 |
-0.50 |
43.9 |
46 |
| VIGL |
Vigil Neuroscience Inc |
-14 M |
|
-46 |
|
10.0 |
0.78 |
0.00 |
-0.20 |
40.6 |
40 |
| VINC |
Vincerx Pharma Inc |
117 M |
|
-129 |
|
17 |
8.6 |
0.00 |
-0.06 |
54.2 |
67 |
| VIR |
Vir Biotechnology Inc |
-48 M |
|
-33 |
|
7.8 |
0.85 |
0.00 |
-0.16 |
38.5 |
36 |
| VIRI |
Virios Therapeutics Inc |
3.5 M |
|
-95 |
|
|
1.8 |
0.00 |
|
63.6 |
92 |
| VIRX |
Viracta Therapeutics Inc |
17 M |
|
-128 |
|
139 |
3.1 |
0.00 |
-0.64 |
59.7 |
85 |
| VKTX |
Viking Therapeutics Inc |
6.2 B |
|
-34 |
|
0.36 |
18 |
0.00 |
-0.02 |
41.7 |
35 |
| VNDA |
Vanda Pharmaceuticals Inc |
-163 M |
94 |
0.47 |
|
1.7 |
0.40 |
1.3 |
0.73 |
12.7 |
3 |
| VOR |
Vor Biopharma Inc |
-95 K |
|
-69 |
|
20 |
0.71 |
0.00 |
-0.39 |
45.2 |
50 |
| VRAX |
Virax Biolabs Group Limited |
-3.8 M |
|
-134 |
|
3.0 |
0.23 |
0.00 |
-0.03 |
38.0 |
35 |
| VRCA |
Verrica Pharmaceuticals Inc |
177 M |
|
-224 |
|
230 |
10.0 |
0.00 |
-1.2 |
67.1 |
106 |
| VRDN |
Viridian Therapeutics Inc |
831 M |
|
-56 |
|
5.0 |
3.9 |
0.00 |
-0.12 |
46.1 |
48 |
| VRNA |
Verona Pharma plc |
9.7 B |
|
-22 |
|
20 |
4.6 |
0.00 |
-1.00 |
50.0 |
58 |
| VRPX |
Virpax Pharmaceuticals Inc |
-7.3 M |
|
-105 |
|
|
0.75 |
0.00 |
|
61.2 |
85 |
| VRTX |
Vertex Pharmaceuticals Incorporated |
97 B |
29 |
22 |
|
4.6 |
6.1 |
36 |
0.23 |
18.5 |
7 |
| VSTM |
Verastem Inc |
216 M |
|
-138 |
|
58 |
5.0 |
0.00 |
-0.53 |
59.5 |
83 |
| VTGN |
VistaGen Therapeutics Inc |
-12 M |
|
-44 |
|
1.8 |
0.91 |
0.00 |
-0.09 |
36.5 |
33 |
| VTVT |
vTv Therapeutics Inc |
48 M |
|
|
|
|
|
0.00 |
|
78.2 |
140 |
| VTYX |
Ventyx Biosciences Inc |
228 M |
|
-64 |
|
5.1 |
1.9 |
0.00 |
-0.08 |
42.3 |
42 |
| VXRT |
Vaxart Inc |
182 M |
|
-97 |
|
34 |
3.1 |
0.00 |
-0.29 |
53.7 |
68 |
| VYGR |
Voyager Therapeutics Inc |
336 M |
3.4 |
89 |
|
8.6 |
1.9 |
52 |
0.26 |
12.2 |
4 |
| VYNE |
VYNE Therapeutics Inc |
-64 M |
|
-46 |
|
0.24 |
0.33 |
0.00 |
-0.01 |
29.7 |
21 |
| WINT |
Windtree Therapeutics Inc |
12 M |
|
-199 |
|
229 |
0.24 |
0.00 |
-1.3 |
54.9 |
71 |
| WVE |
Wave Life Sciences Ltd |
565 M |
|
-1118 |
|
67 |
17 |
-50 |
-1.7 |
73.9 |
128 |
| XBIO |
Xenetic Biosciences Inc |
-3.2 M |
|
-34 |
|
|
0.60 |
-188 |
|
64.0 |
85 |
| XBIT |
XBiotech Inc |
16 M |
|
-10.0 |
|
|
0.99 |
0.00 |
|
54.5 |
61 |
| XCUR |
Exicure Inc |
10 M |
0.35 |
56 |
|
72 |
0.55 |
12 |
-0.32 |
23.0 |
5 |
| XENE |
Xenon Pharmaceuticals Inc |
2.7 B |
|
-22 |
|
1.2 |
3.6 |
0.00 |
-0.08 |
39.4 |
35 |
| XERS |
Xeris Biopharma Holdings Inc |
459 M |
|
-324 |
|
|
|
-37 |
|
82.5 |
161 |
| XLO |
Xilio Therapeutics Inc |
-26 M |
|
-90 |
|
27 |
0.36 |
0.00 |
-0.20 |
44.7 |
48 |
| XNCR |
Xencor Inc |
881 M |
|
-18 |
|
12 |
2.1 |
-74 |
0.98 |
42.2 |
32 |
| XOMA |
XOMA Corporation |
264 M |
|
-38 |
|
140 |
3.3 |
0.00 |
-6.9 |
57.0 |
74 |
| XRTX |
XORTX Therapeutics Inc |
4.9 M |
|
-96 |
|
0.47 |
1.6 |
0.00 |
-0.00 |
34.0 |
22 |
| XTLB |
XTL Biopharmaceuticals Ltd |
564 M |
|
-62 |
|
|
208 |
0.00 |
|
69.8 |
111 |
| YMAB |
Y mAbs Therapeutics Inc |
575 M |
|
-20 |
|
1.4 |
6.4 |
-25 |
-0.05 |
47.2 |
52 |
| YS |
YS Biopharma Co Ltd |
353 M |
|
-61 |
|
99 |
0.11 |
-66 |
-2.5 |
56.6 |
69 |
| ZLAB |
Zai Lab Limited |
17 B |
|
-36 |
|
1.9 |
2.2 |
-125 |
-0.08 |
47.2 |
51 |
| ZNTL |
Zentalis Pharmaceuticals Inc |
551 M |
|
-67 |
|
10.0 |
2.3 |
0.00 |
-0.22 |
47.0 |
52 |
| ZURA |
Zura Bio Limited |
53 M |
25 |
|
|
|
2.1 |
0.00 |
|
60.8 |
75 |
| ZVRA |
Zevra Therapeutics Inc |
177 M |
|
-49 |
|
66 |
3.2 |
-241 |
-2.1 |
64.6 |
99 |
| ZVSA |
ZyVersa Therapeutics Inc |
-536 K |
|
-2368 |
|
0.17 |
0.05 |
0.00 |
-0.00 |
32.2 |
21 |
| ZYME |
Zymeworks Inc |
396 M |
|
-24 |
|
5.8 |
1.6 |
-156 |
-0.23 |
48.3 |
55 |